Use: Labeled indications
- INDICATIONS AND USAGE Perennial Allergic Rhinitis: Cetirizine hydrochloride is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites, animal dander and…
Full indications and usage US FDA label
INDICATIONS AND USAGE Perennial Allergic Rhinitis: Cetirizine hydrochloride is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites, animal dander and molds in children 6 to 23 months of age. Symptoms treated effectively include sneezing, rhinorrhea, postnasal discharge, nasal pruritus, ocular pruritus, and tearing.
Chronic Urticaria: Cetirizine hydrochloride is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in children 6 months to 5 years of age. It significantly reduces the occurrence, severity, and duration of hives and significantly reduces pruritus.
Contraindications
CONTRAINDICATIONS Cetirizine hydrochloride is contraindicated in those patients with a known hypersensitivity to it or any of its ingredients or hydroxyzine.
US FDA labelDosing: Adult
Dosage and administration (US label) US FDA label
DOSAGE AND ADMINISTRATION Cetirizine Hydrochloride Oral Solution, USP 1 mg/mL can be taken without regard to food consumption. Children 2 to 5 Years for Chronic Urticaria: The recommended initial dose of Cetirizine Hydrochloride Oral Solution, USP 1 mg/mL in children aged 2 to 5 years is 2.5 mg (2.5 mL) once daily. The dosage in this age group can be increased to a maximum dose of 5 mg per day given as 5 mL once a day, or 2.5 mL given every 12 hours.
Children 6 Months to <2 Years for Perennial Allergic Rhinitis and Chronic Urticaria: The recommended dose of Cetirizine Hydrochloride Oral Solution, USP 1 mg/mL in children 6 months to 23 months of age is 2.5 mg (2.5 mL) once daily. The dose in children 12 to 23 months of age can be increased to a maximum dose of 5 mg per day, given as 2.5 mL (2.5 mg) every 12 hours.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Syrup: 1 mg/mL, 2.5 mg/5 mL, 2.5 mg/mL, 5 mg/5 mL, 5 mg/mL, 10 mg/mL
- Film-coated tablet: 10 mg
- Tablet: 5 mg/10 mg, 10 mg
- Oral solution: 1 mg/mL, 5 mg/5 mL
- Suspension: 2.5 mg/mL, 10 mg/mL
- ) syrup: 1 mg/mL (5 mg/5 mL, 1 mg/mL (5 mg/mL
- Solution: 10 mg/mL
- Oral drops solution: 2.5 mg/mL, 10 mg/mL
- Syrup [grape flavor]: 2.5 mg/mL
- Syrup grapes flavor: 2.5 mg/mL
and 4 more forms; see the products table.
Registered products in the Philippines
361 products registered with the Food and Drug Administration (FDA) Philippines list Cetirizine as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: Cetirizine Hydrochoride (1 product) · Cetrizine Hydrochloride (1 product) · Citirizine (as Hydrochloride) (1 product, possible match). Products registered under these spellings are included in the table and marked.
All registered products361
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
4lergicCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 40's (Box of 40's and 120's); Alu/Clear PVC Blister Pack x 20's (Box of 100's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-8233 | Feb 24, 2030 | |
AccurecinCetirizine Hydrochloride | 2.5mg/mL Syrup (Oral Drops)Boston Round Amber Bottle x 15mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Curecare Pharmaceutical Products Distribution | DRP-3987-02 | Sep 13, 2027 | |
AccurecinCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Curecare Pharmaceutical Products Distribution | DRP-3522-09 | Feb 1, 2027 | |
AforvirCetirizine Dihydrochloride | 1 mg / mL Oral SolutionAmber Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | ADP Pharma CorporationTrader: Euro-Health Care Exponents, Inc. | DRP-1317-09 | May 4, 2027 | |
AforvirCetirizine Hydrochloride | 10 mg TabletAlu/PVC Blister Pack x 10's Box of 100's | OTC | Micro Labs. LimitedIndia | ADP PHARMA CORPORATIONImporter: Brown & Burk Philippines, Inc. | DRP-275-01 | Apr 10, 2028 | |
AKLERICetirizine dihydrochloride | 10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100’s) | Rx | Akriti Pharmaceuticals Pvt. LtdIndia | Aglobal Care Inc. | DRP-11128 | Sep 29, 2031 | |
AkrizineCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | AKRITI PHARMACEUTICALS PVT. LTD.India | Aglobal Care, Inc. | DRP-14284 | Aug 10, 2028 | |
AlelrmedCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. TOLMANN LABORATORIES INC.Philippines | NUTRAMEDICA INC. | DRP-5754-05 | Mar 12, 2029 | |
Alercet 10Cetirizine Dihydrochloride | 10 mg Film-Coated Tablet | OTC | Zim Laboratories Ltd. | — | DRP-3689 | Mar 27, 2027 | |
ALERESTCetirizine (as Dihydrochloride) | 10 mg TabletAlu/Opaque White PVC Blister Pack x 10’s (Box of 100’s) | Rx | LIFESQUARE LABORATORIES INC.Philippines | WESTPOINT PHARMA INC. | DRP-5185-06 | Mar 3, 2029 | |
AlerestCetirizine Dihydrochloride | 2.5 mg / mL Syrup (Oral Drops)Boston Round Amber Bottle x 15 mL with Medicine Dropper Box of 1's | OTC | LifeSquare Laboratories, Inc.Philippines | Westpoint Pharma Inc. | DRP-5508-08 | Feb 23, 2027 | |
AlerestCetirizine Dihydrochloride | 5 mg / 5 mL SyrupBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | Westpoint Pharma Inc. | DRP-5405-10 | Feb 23, 2027 | |
AlergiquitCetirizine Hydrochloride | 10 mg Tablet2 Composite Packs of Alu/PVC Blister Pack of 5's x 10's Box of 100's | OTC | Stallion Laboratories Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-5546-02 | Sep 26, 2029 | |
AleridCetirizine Dihydrochloride | 10 mg Film-Coated TabletBlister Pack x 20's (Box of 100's) | OTC | Lloyd Laboratories, Inc.Bulacan | Trader: Totalcare Pharma Inc. | DRP-13023 | Dec 28, 2031 | |
AlerSaveCetirizine | 10 mg Film-Coated TabletAlu / Foil Blister Pack x 10's (Box of 100's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Savelink Pharma and Trading Co.Importer: Accesspoint International Trading Inc. | DRP-15601-03 | Aug 8, 2029 | |
AlerzeeCetirizine | 2.5 mg/mL Oral Drops Solution (Apple Flavor)PET Amber Bottle 10 mL and 15mL with medicine dropper (Box of 1's) | OTC | Opal Laboratories (Pvt.) Ltd.Pakistan | Accesspoint International Trading Inc., | DRP-17797 | Mar 12, 2031 | |
Alesof-10Cetirizine dihydrochloride | 10 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | Rx | XL Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-3851 | Jul 1, 2030 | |
AletorCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle with Measuring Cap x 60 mL Box of 1's | OTC | XL Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-3707 | Dec 21, 2029 | |
AlfreeCetirizine Hydrochloride | 10 mg TabletAlu-Clear PVC Blister Pack x 10's (Box of 30's and 100's) | OTC | Stallion Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-6260 | Jun 3, 2028 | |
AlfreeCetirizine dihydrochloride | 10 mg/mL Solution (Oral Drops)Amber PET Bottle x 10 mL (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-9074 | Aug 17, 2030 | |
Alfree 30Cetirizine Dihydrochloride | 5mg/5mL Oral SolutionAmber Glass Bottle x 30mL (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-10130 | Jul 29, 2030 | |
Alfree 60Cetirizine Dihydrochloride | 5 mg/5 mL Oral SolutionAmber Glass Bottle x 60mL (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-10129 | Jul 29, 2031 | |
AlicetCetirizine (as Dihydrochloride) | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Saga Lifesciences LimitedIndia | Hexagon Pharmaceuticals | DR-XY46606 | Jun 4, 2029 | |
AlleclearCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Acme Formulation Pvt. Ltd.India | New Seammed IncImporter: Medinova Pharmaceutical Inc. | DRP-8727-08 | Mar 2, 2031 | |
AllecurCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-8261 | Jul 9, 2029 | |
AllecurCetirizine hydrochloride | 10 mg/mL Syrup (Oral Drops) (Apple Green Flavor)Boston round amber glass bottle with medicine dropper x 10 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-3272 | Sep 22, 2029 | |
AllecurCetirizine Hydrochloride | 5 mg/5 mL Syrup | OTC | AZARIAS PHARMACEUTICAL LABORATORIES INC. | — | DRP-3522 | Feb 1, 2027 | |
Allecur DCetirizine (as dihydrochloride) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-12952 | Nov 9, 2027 | |
Allecur DCetirizine Dihydrochloride | 2.5 mg/ mL Syrup (Oral Drops) [Grape Flavor]Boston Round Amber Glass Bottle x 15 mL with medicine dropper (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-13823 | Apr 27, 2028 | |
Allecur DCetirizine | 5 mg/ 5mL Syrup (Apple Flavor)Boston Round Amber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.,Philippines | — | DRP-14362 | Sep 5, 2028 | |
Allecur PCetirizine Hydrochloride | 2.5mg/mL Syrup (Oral Drops)Boston Round Amber Bottle x 15mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-3987 | Sep 13, 2027 | |
Allecur PlusCetirizine Dihydrochloride Hydrochloride | 5mg/10mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 60's & 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.,Philippines | — | DRP-14228 | Jul 31, 2028 | |
AllercefCetirizine Dihydrochloride | 1 mg/mL Oral SolutionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, IncBulacan | Altomed Pharmaceuticals, Inc.Trader: Euro-Health Care Exponents, Inc. | DRP-1317-06 | May 4, 2032 | |
AllercefCetirizine Dihydrochloride | 10 mg Film-Coated TabletBlister Pack x 20's (Box of 100's) | OTC | Lloyd Laboratories, Inc.Malolos Bulacan | Altomed Pharmaceuticals, Inc.Trader: Euro-Health Care Exponents, Inc. | DRP-920-07 | Mar 14, 2037 | |
AllerchemCetirizine Hydrochloride | 5 mg/5 mL Syrup (Grapes Flavor)PET Round Amber Bottle with White HDPE Cap x 60 mL & 120 mL (Box of 1's) | OTC | Mascot Health Series Pvt. Ltd.India | Importer: Wellchem Pharmaceutical Products | DRP-9657 | Apr 22, 2031 | |
AllerEraseCetirizine Hydrochloride | 10 mg TabletAlu-Clear PVC Blister Pack x 10’s (Box of 100's) | OTC | Stallion Laboratories Pvt. Ltd.India | TGP Pharma Inc.Importer: Ambica International Corporation | DRP-6260-04 | Jun 3, 2028 | |
AllerfedCetirizine | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's, 50's & 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Bulacan | Federal Pharmaceuticals Inc. | DRP-16483-07 | Mar 25, 2030 | |
AllerhealCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 40's (Box of 40's and 120's); Alu/Clear PVC Blister Pack x 20's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Hale Medipoint Corp. | DRP-5427-12 | Aug 8, 2029 | |
AllerhealCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Hale Medipoint Corp. | DRP-3522-10 | Feb 1, 2027 | |
AllerjecCetirizine Dihydrochloride | 2.5mg/5mL Syrup (Drops) (Grape flavor)PET Round Amber Bottle x 10 mL, 15 mL and 30 mL (Box of 1's) | Rx | Mascot Health Series Pvt. Ltd.India | Wellchem Pharmaceutical Product | DRP-11903 | May 18, 2027 | |
AllerkidCetirizine dihydrochloride | 2.5 mg/ mL Syrup (Oral Drops)Amber Glass Bottle x 10 mL with Dropper (Box of 1's) | OTC | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DRP-13730 | Apr 6, 2031 | |
AllerkidCetirizine dihydrochloride | 5 mg/ 5 mL Syrup (Grape Flavor)Amber Glass Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DRP-13729 | Jul 12, 2031 | |
AllermedCetirizine dihydrochloride | 1 mg/mL Oral SolutionAmber bottle x 30 mL Box of 1's; Amber Bottle x 60 mL Box of 1's | Rx | Lloyd Laboratories, Inc.Philippines | Nutramedica IncTrader: Euro-Health Care Exponents, Inc. | DRP-1317-02 | May 4, 2027 | |
AllermedCetirizine hydrochloride | 10 mg Film Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Interphil Laboratories, Inc.Philippines | Nutramedica, Inc. | DRP-1469-06 | Jan 31, 2028 | |
AllermedCetirizine Dihydrochloride | 10 mg Film-Coated TabletBlister Pack x 20's (Box 100's) | OTC | Lloyd Laboraties Inc.Bulacan | Nutramedica Inc.Trader: Eurohealth Care Exponents, Inc. | DRP-920-01 | Mar 14, 2032 | |
AllerpenCetirizine | 5mg/5mL SyrupAmber PET Bottle x 30mL and 60mL (Box of 1's) | OTC | Rhydburg Pharmaceuticals LimitedIndia | A. Pendragon International Distribution OpcImporter: Khriz Pharma Trading Inc. | DRP-11267-01 | Feb 21, 2027 | |
AllerphilCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Mercury Laboratories Ltd.India | Philgen Pharmaceuticals Inc. | DRP-12917 | Oct 28, 2027 | |
AllersafeCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Mercury Laboratories Ltd.India | Meedpharma Medical Supplies and Equipment DistributorImporter: Philgen Pharmaceuticals Inc. | DRP-12917-02 | Oct 28, 2027 | |
AllerstopCetirizine dihydrochloride | 10 mg Film-Coated TabletAluminum foil/PVC film clear blister pack x 20’s Box of 10's and 30's | OTC | Phil. United Pharma CorporationPhilippines | ATC Healthcare International Corp. | DRP-7467 | Nov 16, 2027 | |
AllerstopCetirizine Dihydrochloride | 5 mg/5 mL Syrup (Grape Flavor)Round Glass Amber Bottle with Foam-lined Aluminum Cap with PSP liner and 20 mL PET Measuring Cup x 60 mL, 120 mL, 250 mL and 500 mL (Box of 1’s) | OTC | Phil. United Pharma CorporationPhilippines | Trader: A.T.C Health Care International Corp. | DRP-18833 | Sep 15, 2031 | |
AllerstopCetirizine Dihydrochloride | 5 mg/5 mL Syrup (Grape Flavor)Round PET Amber Bottle with HDPE Bottle Cap and 20 mL PET Measuring Cup x 60 mL, 120 mL and 250 mL (Box of 1’s) | OTC | Phil. United Pharma CorporationPhilippines | Trader: A.T.C Health Care International Corp. | DRP-18836 | Sep 15, 2031 | |
AllerteenCetirizine Dihydrochloride | 10 mg Film-Coated TabletBlister Strip x 20's (Box of 100's) | Rx | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY46859 | Mar 25, 2030 | |
ALLERWELLCetirizine Hydrochloride | 5 mg/5 mL SyrupPET Round Amber Bottle with White HDPE Cap x 60 mL & 120 mL Box of 1's | OTC | Mascot Health Series Pvt. Ltd.India | Davao Point Pharmaceutical ProductsImporter: Wellchem Pharmaceutical Products | DRP-9657-01 | Apr 22, 2031 | |
AlletrinCetirizine Dihydrochloride | 10 mg TabletBlister Pack x 10's (Box of 100's) | OTC | Hizon Laboratories, Inc.Philippines | — | DRP-740 | Aug 30, 2027 | |
AlletrinCetirizine Dihydrochloride | 5 mg/5 mL Syrup60 mL Boston Round Amber Bottle sealed with White Aluminum Cap (Box of 1's) | OTC | Hizon Laboratories, Inc.Philippines | — | DRP-6229 | Jun 30, 2029 | |
AllezalCetirizine Dihydrochloride | 1 mg/mL Oral SolutionAmber Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Wecare Pharma Corp.Trader: Euro-Health Care Exponents, Inc. | DRP-1317-08 | May 4, 2027 | |
ALLEZALCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. TOLMANN LABORATORIES INC.Philippines | WECARE PHARMA CORP. | DRP-5754-08 | Mar 12, 2029 | |
AlnixCetirizine dihydrochloride | 2.5 mg / mL Syrup (Oral Drops) [Grape Flavor]Amber Glass Bottle x 10 mL (Box of 1's) | OTC | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DRP-14187 | Apr 6, 2031 | |
AlnixCetirizine dihydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 30 mL and 60 mL (Box of 1's) | Rx | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DRP-14131 | Jul 12, 2031 | |
AlrezinCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | Rx | Mercury Laboratories Ltd.India | Phil Pharmawealth, Inc. | DR-XY45335 | Apr 28, 2031 | |
AmizitCetirizine (as Dihydrochloride) | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Amiel Trading Inc. | DRP-12952-02 | Nov 9, 2027 | |
AriztCetirizine (as hydrochloride) | 10 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 10 blister packs x 10 tablets) | Rx | Magbro Healthcare Pvt. Ltd.India | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP- 14046-02 | Jun 8, 2028 | |
AskeyCetirizine Hydrochloride | 10 mg tabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Micro Labs Ltd.India | Brown & Burk Phils., Inc. | DRP-275 | Apr 10, 2028 | |
Askey DTCetirizine ( as hydrochloride ) | 5 mg Dispersible tabletAluminum Foil Strip x 10's (Box of 100's) | OTC | Micro Labs LimitedIndia | Brown & Burk Philippines Inc. | DR-XY42229 | Jul 15, 2028 | |
AthcetCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Athens Life SciencesIndia | Khriz Pharma Trading Inc | DR-XY49763 | Jul 7, 2031 | |
AztirineCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu-PVC Blister Pack x 10’s (Box of 30's and 100's) | OTC | Fredun Pharmaceuticals LimitedIndia | AMB HK Enterprises Inc.Importer: PhilRx Pharma Inc. | DRP-8861-05 | May 18, 2031 | |
Benadryl OneCetirizine hydrochloride | 10 mg Film-Coated TabletPVC/PE/PVDC Blister Pack x 10's (Box of 100's) | OTC | Janssen-Cilag S.P.AItaly | JNTL Consumer Health (Philippines) Inc. | DR-XY49097 | May 29, 2029 | |
Benadryl OneCetirizine hydrochloride | 10 mg Film-Coated TabletPVC/PVDC Blister Pack x 10's (Box of 100's) | OTC | Janssen-Cilag S.P.A.Italy | JNTL Consumer Health (Philippines) Inc. | DR-XY49098 | May 29, 2029 | |
Benadryl OneCetirizine hydrochloride | 10 mg film-coated tabletAlu/Clear PVC Blister pack x 10's (Box of 100's); Alu/Clear PVC Blister pack x 2's (Box of 4's) | OTC | Interphil Laboratories, Inc.Philippines | Trader: Johnson & Johnson (Philippines), Inc. | DRP-1469-02 | Jan 31, 2028 | |
CertcareCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu PVC Blister Pack x 10's (Box of 100's) | OTC | Uniza Lifecare Pvt. Ltd.India | Lealmeds Pharmaceutical Inc.\Trader: M/S Pharmacare | DRP-16658 | May 30, 2030 | |
CETALERTCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. TOLMANN LABORATORIES INC.Philippines | WESTFIELD PHARMACEUTICALS, INC. | DRP-5754-10 | Mar 12, 2029 | |
Ceti-MedCetirizine (as Dihydrochloride) | 1 mg/mL Oral SolutionAmber Glass Bottle x 30 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY36424 | Aug 7, 2029 | |
Ceti-MedCetirizine Dihydrochloride | 10 mg Film-Coated TabletClear PVDC Blister Pack x 10's (Box of 100's) | OTC | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma Inc. | DR-XY35277 | Jan 7, 2029 | |
Ceti-MedCetirizine (as Dihydrochloride) | 10 mg/mL Suspension (Oral Drops)Amber Glass Bottle with medicine dropper x 15 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY36423 | Aug 7, 2029 | |
CetiairCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Ntpk Pharma And Medical Supplies Distributor | DRP-3522-12 | Feb 1, 2027 | |
CeticitCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu-PVC Blister Pack x 10’s (Box of 30’s and 100’s) | Rx | Fredun Pharmaceuticals LimitedIndia | AMB HK Enterprises Inc. | DRP-8861 | May 18, 2031 | |
CetiCureCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | JAAC HEALTHLINE MARKETING | DRP-5427-09 | Aug 8, 2029 | |
Ceticure ODCetirizine Hydrochloride | 2.5mg/mL Syrup (Oral Drops)Boston Round Amber Bottle x 15mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories, Inc.Philippines | Jaac Healthline Marketing | DRP-3987-09 | Sep 13, 2027 | |
Ceticure SCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Jaac Healthline Marketing | DRP-3522-18 | Feb 1, 2027 | |
CetigoldCetirizine | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box (Box of 30's, 50's & 100's) | OTC | Azarias Pharmaceutical Laboratories IncPhilippines | Brilliantmeed, Inc. | DRP-16483-05 | Mar 25, 2030 | |
Cetigold ODCetirizine Hydrochloride | 2.5mg/mL Syrup (Oral Drops)Boston Round Amber Bottle x 15mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Brilliantmeed, Inc. | DRP-3987-07 | Sep 13, 2027 | |
Cetigold SCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Brilliantmeed, Inc. | DRP-3522-16 | Feb 1, 2027 | |
CetiredCetirizine (as Hydrochloride) | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | SAPPHIRE LIFESCIENCES PVT. LTDIndia | 777 Red Pharma IncImporter: NELPA LIFESCIENCES, INC. | DRP-5176-01 | Feb 27, 2029 | |
CetiredCetirizine (as Hydrochloride) | 10 mg TabletAlu/Clear PVC Blister Pack x 10’s (Box of 100's) | OTC | Genom Biotech Pvt. Ltd.India | 777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc. | DRP-5176-02 | Mar 21, 2031 | |
CetiredCetirizine Hydrochloride | 2.5 mg/mL Syrup (Oral Drops)PET Round Amber Bottle with White HDPE Cap x 15 mL and 30 mL with Medicine Dropper (Box of 1's); PET Round Amber Bottle with White HDPE Cap x 15 mL (10 mL net Content) with Medicine Dropper (Physician Sample) (Box of 1's) | OTC | Enicar Pharmaceuticals Pvt. Ltd.India | 777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-9294-03 | Nov 18, 2030 | |
CetirexCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-6813 | Aug 26, 2031 | |
CetirexCetirizine Hydrochloride | 10 mg/mL Syrup (Oral Drops)Amber Bottle x 10 mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-6811 | Aug 26, 2031 | |
CetirexCetirizine Hydrochloride | 5mg/5mL Syrup (Grape Flavor)Amber Bottle x 30 mL and 60 mL (Box of 1's) | Rx | New Myrex Laboratories, Inc.Philippines | — | DRP-6812 | Aug 26, 2031 | |
Cetirex-LDCetirizine Hydrochloride | 2.5 mg/mL Syrup (Oral Drops) Grape FlavorAmber Boston Round Glass Bottle x 15mL with Dropper and Cap (Box of 1's) | OTC | New Myrex Laboratories, Inc.Philippines | — | DRP-10572 | Oct 18, 2031 | |
CETIRGENCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. TOLMANN LABORATORIES INC.Philippines | QUAD-GEN PHARMACEUTICALS | DRP-5754-09 | Mar 12, 2029 | |
Cetiri-BrillCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. Tolmann Laboratories, Inc.Philippines | Rcbrilliant Pharma Corp. | DRP-5754-15 | Mar 12, 2029 | |
CetiridCetirizine Hydrochloride | 10 mg Film-Coated TabletClear PVDC Blister Pack x 10's (Box of 100's) | OTC | Lloyd Laboratories, Inc.Philippines | Trader: Gold Life Distribution Phils. Inc. | DRP-6875 | Nov 21, 2027 | |
CetirifedCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 40's (Box of 40's and 120's); Alu/Clear PVC Blister Pack x 20's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Federal Pharmaceuticals Inc. | DRP-5427-13 | Aug 8, 2029 | |
CetirifedCetirizine Hydrochloride | 2.5mg/mL Syrup (Oral Drops)Boston Round Amber Bottle x 15mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Federal Pharmaceuticals Inc. | DRP-3987-03 | Sep 13, 2027 | |
CetirifedCetirizine | 5 mg/5 mL Syrup (Apple Flavor)Boston Round Amber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Federal Pharmaceuticals Inc. | DRP-14362-01 | Sep 5, 2028 | |
CetirigenCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-5427-01 | Aug 8, 2029 | |
CetirigenCetirizine Hydrochloride | 2.5 mg/ mL Syrup (Oral Drops)Boston Round Amber Glass Bottle x 10 mL (Box of 1's) | OTC | AZARIAS PHARMACEUTICAL LABORATORIES INC.Philippines | EBA GENERISCH TRADING INC. | DRP-4067-02 | Oct 19, 2027 | |
CetirigenCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | EBA Generisch Trading Inc. | DRP-3522-02 | Feb 1, 2027 | |
CetirikhrizCetirizine | 5 mg/ 5 mL Oral Solution (Raspberry Flavor)Round Amber PET Bottle x 60mL (Box of 1’s) | OTC | Samson Laboratories Pvt. Ltd.India | Khriz Pharma Trading Inc. | DRP-18659 | Aug 13, 2031 | |
CetirilifeCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | ACME Formulation Pvt. Ltd.India | Life and Health Source Pharmaceutical Distribution Co.Importer: Medinova Pharmaceutical Inc. | DRP-8727-03 | Feb 20, 2031 | |
CetirinavCetirizine Hydrochloride | 10 mg TabletPVC / ALU Blister Pack x 10's (Box of 100's) | OTC | Scheele Laboratories Phils., Inc.Philippines | JN Carlo Pharmaceuticals | DRP-1353-04 | Apr 13, 2029 | |
CetirineCetirizine Hydrochloride | 10 mg Film-Coated TabletBlister Pack x 10's (Box of 100's) | OTC | Hizon Laboratories, Inc.Philippines | Sigma Medical Solution Trading Co., Inc. | DRP-1896 | Jan 30, 2028 | |
CetirivinCetirizine Dihydrochloride | 10 mg TabletAlu/PVC Blister Pack x 10’s (Box of 100’s) | OTC | Umedica Laboratories Pvt. Ltd.India | Pharmaxicare Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1182-05 | Dec 16, 2028 | |
CetironCetirizine Dihydrochloride | 10 mg TabletAlu/PVC Blister Pack x 10’s (Box of 100’s) | OTC | Umedica Laboratories Pvt. Ltd.India | Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1182-03 | Dec 16, 2028 | |
CetivarozCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Zim Laboratories Ltd.India | Varoz MarketingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3689-04 | Mar 27, 2032 | |
CetivarozCetirizine Hydrochloride | 10 mg TabletAlu-Clear PVC Blister Pack x 10’s (Box of 100’s) | OTC | Stallion Laboratories Pvt. Ltd.India | Varoz MarketingImporter: Ambica International Corporation | DRP-6260-05 | Jun 3, 2028 | |
CetizanCetirizine Hydrochloride | 5mg/ 5mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Triple 888 Medical And Pharma Inc. | DRP-3522-13 | Feb 1, 2027 | |
Cetizan 10Cetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Triple 888 Medical and Pharma Inc. | DRP-8261-01 | Jul 9, 2029 | |
Cetizan ODCetirizine Hydrochloride | 2.5 mg/mL Syrup (Oral Drops)Boston Round Amber Bottle x 15mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Triple 888 Medical And Pharma Inc. | DRP-3987-04 | Sep 13, 2027 | |
CetizinCetirizine Hydrochloride | 1 mg/mL Oral SolutionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Bulacan | TGP Pharma Inc.Trader: Euro-Health Care Exponents, Inc. | DRP-1317-01 | May 4, 2032 | |
Cetizine 10Cetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Centurion Laboratories Pvt. Ltd.India | TGP Pharma Inc.Importer: Philgen Pharmaceuticals Inc. | DRP-10725-02 | Nov 15, 2031 | |
CetrexzineCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. Tolmann Laboratories, Inc.Philippines | Rexmed Pharmaceutical Sales | DRP-5754-13 | Mar 12, 2029 | |
CetricareCetirizine | 10 mg Film-Coated TabletAlu/Foil Blister Pack x 10's (Box of 100's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Medcare PharmaceuticalsImporter: Accesspoint International Trading Inc. | DRP-15601-01 | Aug 8, 2029 | |
Cetricare-HCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | AKRITI PHARMACEUTICALS PVT. LTD.India | MEDCARE PHARMACEUTICALSImporter: AGLOBAL CARE, INC. | DRP-14284-01 | Aug 10, 2028 | |
Cetricare-SCetirizine | 5 mg / 5 mL Oral Solution (Apple Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Medcare PharmaceuticalsImporter: Accesspoint International Trading Inc. | DRP-15602-02 | Aug 8, 2029 | |
CetriGetCetirizine Hydrochloride | 10 mg Tablet | OTC | West Coast Pharmaceutical Works Ltd.India | 2MG Incorporated | DRP-17548 | Feb 9, 2031 | |
CetrignaCetirizine Hydrochloride | 10 mg Tablet2 Composite packs of Alu/PVC Blister Pack of 5 x 10's (Box of 100's) | OTC | Stallion Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-5546 | Sep 26, 2029 | |
CetrimaxCetirizine Hydrochloride | 10 mg TabletAlu-Alu Blister Pack x 10's (Box of 100's) | Rx | Zest PharmaIndia | Sahar International Trading Inc.Trader: NGB Laboratories Pvt. Ltd. | DR-XY41282 | Aug 9, 2029 | |
CetrimolCetirizine Hydrochloride | 10 mg TabletAlu-PVC Clear Blister Pack x 10's (Box of 100's) | OTC | Den Mark Pharmaceuticals Pvt. Ltd.India | Anmol Pharmaceuticals US Corp. | DRP-18716 | Aug 27, 2031 | |
10 mg Film-Coated TabletAlu/PVC Blister x 10's (Box of 100's) | Rx | ACME Formulation Pvt. Ltd.India | Medinova Pharmaceutical Inc. | DRP-8727 | Feb 9, 2037 | ||
CETRIPHILCetirizine Dihydrochloride | 10 mg Film Coated TabletAlu/PVC Clear Blister Pack x 's (Box of 's) | OTC | Exemed PharmaceuticalsIndia | AMB HK Enterprises, Inc. | DRP-18801 | Sep 8, 2031 | |
Cetrisaph-5Cetirizine Hydrochloride | 5 mg/5 mL Syrup (Orange Flavor)PET Round Amber Bottle with White ROPP Cap x 60 mL and 120 mL (Box of 1’s) | OTC | Enicar Pharmaceuticals Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-9718 | Aug 24, 2031 | |
Cetrisaph-ODCetirizine hydrochloride | 2.5 mg/mL Syrup (Oral Drops)PET Round Amber Bottle with White ROPP Cap x 15 mL and 30 mL with Medicine Dropper (Box of 1’s) | OTC | Enicar Pharmaceuticals Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-9294 | Aug 24, 2031 | |
CetrisetCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | 999 SETH PHARMACEUTICAL INC. | DRP-5427-03 | Aug 8, 2029 | |
CetrisetCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | 999 Seth Pharmaceutical Inc. | DRP-3522-01 | Feb 1, 2027 | |
CetrivalCetirizine | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's, 50's & 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-16483 | Mar 25, 2030 | |
CetrivalCetirizine hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's, 50's & 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-16483-06 | Mar 25, 2030 | |
Cetrival ODCetirizine Hydrochloride | 2.5mg/mL Syrup (Oral Drops)Boston Round Amber Bottle x 15mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-3987-08 | Sep 13, 2027 | |
Cetrival SCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-3522-17 | Feb 1, 2027 | |
CetriwinCetirizine (as Dihydrochloride) | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Mediwin PharmaceuticalsIndia | Medcare PharmaceuticalsImporter: Ambica International Corporation | DRP-4472 | Jun 13, 2028 | |
1 mg/mL SyrupPET Plastic Bottle x 60 mL (Box of 1's) | OTC | Y.S.P. Industries (M) Sdn. Bhd.Malaysia | Yung Shin (Philippines), Inc. | DRP-8764 | Mar 23, 2037 | ||
CetrizilCetirizine Hydrochloride | 10 mg Film-Coated TabletClear PVC-Alu Blister Pack x 10's (Box of 100's) | Rx | Y.S.P. Industries (M) Sdn. Bhd.Malaysia | Yung Shin (Philippines), Inc. | DR-XY38609 | Oct 12, 2030 | |
CetzyCetirizine Hydrochloride | 5 mg/5 mL SyrupPET Amber Bottle x 60 mL (Box of 1's) | Rx | Zee LaboratoriesIndia | Importer: Eon Pharmatek Inc. | DR-XY47357 | Aug 12, 2031 | |
Cetzy-10Cetirizine Hydrochloride | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Zee LaboratoriesIndia | EON Pharmatek, Inc | DR-XY37812 | Apr 28, 2031 | |
CiticureCetirizine | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Ratnatris Pharmaceutical Pvt. Ltd.India | TGIF Pharmaceutical Trading IncImporter: Medinova Pharmaceutical Inc. | DRP-8451-01 | Oct 9, 2029 | |
CiticureCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. TOLMANN LABORATORIES INC.Philippines | TGIF PHARMACEUTICAL TRADING INC. | DRP-5754-12 | Mar 12, 2029 | |
CiticureCetirizine Hydrochloride | 5 mg / 5 mL Oral SolutionAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Scheele Laboratories Phils., Inc.Philippines | TGIF Pharmaceutical Trading Inc. | DRP-1352-05 | Apr 13, 2029 | |
CitrexzineCetirizine | 5 mg / 5 mL Oral Solution (Apple Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading | DRP-15602-03 | Aug 8, 2029 | |
CTZCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Strip x 10's (Box of 100's) | Rx | Delta Pharma Ltd.Bangladesh | BioMed Pharma Inc., | DR-XY38744 | Nov 15, 2030 | |
CTZCetirizine (as dihydrochloride) | 5 mg/5mL SYRUPType II Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Delta Pharma Ltd.Bangladesh | Biomed Pharma Inc. | DR-XY47159 | Feb 4, 2031 | |
Cyndifixx 10Cetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | PSA Chemicals & Pharmaceuticals Pvt. Ltd.India | Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-16554 | Apr 29, 2030 | |
CyntrexCetirizine Hydrochloride | 5 mg/5 mL syrupAmber Glass Bottle with White Aluminum Cap x 30 mL, 60 mL and 120 mL (Box of 1's); Amber Glass Bottle with White Aluminum Cap x 5 mL and 10 mL as Physician's Sample (Box of 1's) | OTC | Interphil Laboratories, Inc.Philippines | — | DRP-1468 | Mar 23, 2031 | |
Cyntrex (Reformulated)Cetirizine hydrochloride | 10 mg Film Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's and 10's); Alu/Clear PVC Blister Pack x 2's (Box of 4's); Alu/Clear PVC Blister Pack x 2's (Physician's Sample) | OTC | Interphil Laboratories, Inc.Philippines | — | DRP-1469 | Jan 31, 2028 | |
DialixCetirizine Hydrochloride | 1 mg/mL Oral SolutionAmber Glass Bottle x 60mL (Box of 1’s) | OTC | Diamond Laboratories Inc.Philippines | Rilem Pharma Corp. | DRP-7172 | Jan 31, 2028 | |
DialixCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | OTC | Diamond Laboratories, Inc.Philippines | Rilem Pharma Corp. | DRP-7118 | Jul 14, 2029 | |
DialixCetirizine Hydrochloride | Banana Flavor 2.5 mg / mL Syrup (Oral Drops)Boston Round Amber Bottle with Pilfer Proof Metal Cap with Medicine Dropper x 15 mL (Box of 1's) (Box of 1's) | OTC | Diamond Laboratories Inc.Philippines | Rilem Pharma Corp. | DRP-11109 | Feb 17, 2032 | |
DumparinCetirizine Dihydrochloride | 10 mg TabletAlu/PVC Blister Pack x 10’s (Box of 100’s) | OTC | Umedica Laboratories Pvt. Ltd.India | Jjysrinn Trading Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1182-04 | Dec 16, 2028 | |
DymeralCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Unicure Remedies Pvt. Ltd.India | Jjysrinn Trading Inc.Importer: Ambica International Corporation | DRP-4360 | Apr 8, 2028 | |
EfrizineCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Syncom Formulations (India) Ltd.India | Bansan Pharma DistributorImporter: Arvincare Pharma Inc. | DRP-3139-01 | Jul 27, 2028 | |
ElbacetCetirizine (as Hydrochloride) | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Pharmatec Pakistan (Pvt.) Ltd.S.I.T.E. Pakistan | Amediqo Phils., Inc.Importer: Sahar International Trading Inc. | DRP-4198-02 | Jun 9, 2031 | |
EocetCetirizine Hydrochloride | 10mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Umedica Laboratories Pvt. Ltd.India | Eon Pharmatek Inc | DR-XY47348 | Aug 6, 2031 | |
EozetCetirizine Hydrochloride | 10 mg Film Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Ciron Drugs & Pharmaceuticals Pvt. LtdIndia | EON Pharmatek, IncTrader: Subira Pharmaceuticals Pvt. LTD | DRP-8556 | Jan 20, 2030 | |
ErazinCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Errapel Pharmed Corp. | DRP-3522-11 | Feb 1, 2027 | |
ErilifeCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30’s and 100’s) | OTC | Fredun Pharmaceuticals LimitedIndia | Life And Health Source Pharmaceutical Distribution Co.Importer: Philrx Pharma, Inc. | DRP-8861-03 | May 18, 2031 | |
ErilifeCetirizine dihydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Hebei Tiancheng Pharmaceutical Co., Ltd.China | Life and Health Source Pharmaceutical Distribution Co.Importer: AMB HK Enterprises Inc. | DRP-9024-01 | Jul 6, 2031 | |
EtirizCetirizine Dihydrochloride | 10 mg Film-Coated TabletBlister Pack x 20's (Box of 100's) | OTC | Lloyd Laboraties Inc.Bulacan | Medirich Pharma Distribution Corp.Trader: Eurohealth Care Exponents, Inc. | DRP-920-04 | Mar 14, 2032 | |
ETIRIZCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. TOLMANN LABORATORIES INC.Philippines | MEDIRICH PHARMA DISTRIBUTION CORP. | DRP-5754-01 | Mar 12, 2029 | |
F-ZeenCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. Tolmann Laboratories, Inc.Philippines | Frontida Pharmaceutical Distributor | DRP-5754-11 | Mar 12, 2029 | |
GleezineCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's Box of 100's | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | GSP ENTERPRISES | DRP-5427-06 | Aug 8, 2029 | |
GleezineCetirizine Hydrochloride | 2.5 mg/mL Syrup (Oral Drops)Boston Round Amber Glass Bottle x 10 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | GSP Enterprises | DRP-4067-04 | Oct 19, 2028 | |
GleezineCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | GSP Enterprises | DRP-3522-05 | Feb 1, 2027 | |
GoticitCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu-PVC Blister Pack x 10’s (Box of 30’s and 100’s) | OTC | Fredun Pharmaceuticals LimitedIndia | Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc. | DRP-8861-02 | May 18, 2031 | |
GotirizineCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | ACME Formulation Pvt. Ltd.India | Applied Pharmaceutical Distribution IncImporter: Medinova Pharmaceutical Inc. | DRP-8727-04 | Feb 20, 2031 | |
GrazineCetirizine dihydrochloride | 10 mg/mL Oral DropsAmber Colored PET Bottle x 20 mL (Box of 1's) | OTC | Gracure Pharmaceutical Ltd.India | Aglobal Care, Inc. | DRP-14674 | Nov 22, 2028 | |
H-ONECetirizine (as hydrochloride) | 1 mg/mL Oral SolutionAmber Bottle x 30 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Terramedic, Inc. | DR-XY35936 | May 29, 2031 | |
H-OneCetirizine Dihydrochloride | 10 mg TabletPVC/Alu Blister Pack x 10's (Box of 100's) | OTC | Drugmaker's Laboratories, Inc.Philippines | Terramedic, Inc. | DRP-262-01 | Jun 21, 2027 | |
H-OneCetirizine Hydrochloride | 2.5 mg/mL Syrup (Oral Drops)Amber Glass Bottle x 10 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Laguna | Trader: Terramedic, Inc. | DR-XY37470 | Feb 17, 2032 | |
HistacetCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | ACME Formulation Pvt. Ltd.India | Skymed Pharma DistributorImporter: Medinova Pharmaceutical Inc. | DRP-8727-07 | Feb 24, 2031 | |
HistagicCetirizine (as Dihydrochloride) | 10 mg TabletAlu/Clear PVC Blister Pack X 20's (Box of 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Errapel Pharmed Corp. | DRP-12952-01 | Nov 9, 2027 | |
HistamedCetirizine Hydrochloride | 1 mg/mL Oral SolutionAmber Bottle x 30 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DRP-8610 | Apr 23, 2027 | |
HistamedCetirizine Hydrochloride | 10 mg Film-Coated TabletBlister Pack x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DRP-8609 | May 18, 2031 | |
HistanovCetirizine | 1 mg/mL Oral Solution (Banana Flavor)Amber PET Bottle with ROPP Cap x 30 mL, 60 mL, and 100 mL (Box of 1's) | OTC | S Kant Healthcare Ltd.India | Medinova Pharmaceutical Inc. | DRP-15558 | Aug 6, 2029 | |
Histar-DxCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | OTC | MAGBRO HEALTHCARE PVT. LTD.India | Teramedix Pharma Trading Inc. | DRP-14456 | Sep 8, 2028 | |
Histasaph-5Cetirizine Hydrochloride | 1 mg/mL (5 mg/mL) Syrup (Orange Flavor)PET Round Amber Bottle with White ROPP Aluminum Cap x 60 mL (Box of 1's); PET Round Amber Bottle with White ROPP Aluminum Cap x 120 mL (Box of 1's) | OTC | Azine Healthcare Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-10843 | Dec 6, 2031 | |
Histasaph-ODCetirizine Hydrochloride | 2.5 mg/mL Syrup (Oral Drops) (Orange Flavor)PET Round Amber Bottle with White ROPP Aluminum Cap with Plastic Dropper x 15 mL (Box of 1's); PET Round Amber Bottle with White ROPP Aluminum Cap with Plastic Dropper x 30 mL (Box of 1's) | OTC | Azine Healthcare Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-10839 | Dec 6, 2031 | |
HistazineCetirizine Dihydrochloride | 1 mg/mL Oral SolutionAmber Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Bulacan | Hei Gruppo Pharmaceutica, Inc.Trader: Euro-Health Care Exponents, Inc. | DRP-1317 | May 4, 2032 | |
HIstazineCetirizine Dihydrochloride | 10 mg Film-Coated TabletBlister Pack x 20's (Box of 100's) | OTC | Lloyd Laboratories, Inc.Philippines | HEI Gruppo Pharmaceutica, Inc.Trader: Euro-Health Care Exponents, Inc. | DRP-920 | Mar 14, 2027 | |
HistrizineCetirizine Hydrochloride | 1 mg/mL Oral SolutionAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Scheele Laboratories Phils., Inc.Philippines | Zeutica, Inc. | DRP-1352-02 | Apr 13, 2029 | |
HISTRIZINECETIRIZINE HYDROCHLORIDE | 10 mg TabletPVC/Alu Blister Pack x 10's (Box of 100's) | OTC | SCHEELE LABORATORIES PHILS., INC.Philippines | ZEUTICA, INC. | DRP-1353-02 | Apr 13, 2029 | |
ICHIGONCetirizine Dihydrochloride | 10mg Film-Coated TabletAlu/Clear PVC Blister Pack x 20’s (Box of 100’s) | OTC | San Marino Laboratories CorporationPhilippines | — | DRP-18119 | May 6, 2031 | |
Irizine-10Cetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Centurion Laboratories Pvt. Ltd.India | Philgen Pharmaceuticals Inc. | DRP-10725 | Nov 15, 2031 | |
IzeenCetirizine hydrochloride | 5 mg / 5 mL SyrupAmber Glass Bottle x 60 mL N/A | Rx | Pharmatec Pakistan (Pvt.) Ltd.Pakistan | Ellebasy Medicale TradingImporter: Sahar International Trading Inc | DRP-4198-01 | Jun 9, 2031 | |
IzzinCetirizine Hydrochloride | 5 mg/5 mL Syrup (Apple Flavor)Boston Round Amber Bottle with Metal Cap x 60mL (Box of 1's) | OTC | Fortis Medi Pharmaceutical, Inc.Philippines | Trader: D & G Pharma | DRP-17622 | Feb 10, 2031 | |
JhiscetCetirizine Dihydrochloride | 5 mg / 5 mL SyrupBoston Round Amber Bottle x 60 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | Jhisreh Medica Co., Ltd. | DRP-5405-12 | Feb 23, 2027 | |
KalanitCetirizine Hydrochloride | 10 mg TabletAlu-Clear PVC Blister Pack x 10's (Box of 30's and 100's) | OTC | Stallion Laboratories Pvt. Ltd.India | Kaufmann Pharma Inc.Importer: Ambica International Corporation | DRP-6260-01 | Jun 3, 2028 | |
KotirzinCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Konzept Convenience and Drug Store Corp. | DRP-5427-05 | Aug 8, 2029 | |
KotirzinCetirizine Hydrochloride | 2.5 mg/mL Syrup (Oral Drops) Grapes FlavorBoston Round Amber Glass Bottle x 10 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Konzept Convenience And Drug Store Corp. | DRP-4067-05 | Oct 19, 2027 | |
KotirzinCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Konzept Convenience And Drug Store Corp. | DRP-3522-06 | Feb 1, 2027 | |
LergenCetirizine | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's, 50's & 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-16483-01 | Mar 25, 2030 | |
Lergen ODCetirizine Hydrochloride | 2.5mg/mL Syrup (Oral Drops)Boston Round Amber Bottle x 15mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-3987-05 | Sep 13, 2027 | |
Lergen-SCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-3522-14 | Feb 1, 2027 | |
LergicCetirizine (as Dihydrochloride) | 10 mg TabletAlu/Opaque White PVC Blister Pack x 10’s (Box of 100’s) | Rx | Lifesquare Laboratories Inc.Philippines | Novomed Inc. | DRP-5185-07 | Mar 3, 2029 | |
LergicCetirizine Dihydrochloride | 2.5 mg / mL Syrup (Oral Drops)Boston Round Amber Bottle x 15 mL with Medicine Dropper Box of 1's | Rx | LifeSquare Laboratories, Inc.Philippines | Novomed Inc. | DRP-5508-03 | Feb 23, 2027 | |
LergicCetirizine Dihydrochloride | 5 mg / 5 mL SyrupBoston Round Amber Bottle x 60 mL (Box of 1's); Boston Round Amber Bottle x 30 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | Novomed Inc. | DRP-5405-03 | Feb 23, 2027 | |
LERIFCetirizine (as Dihydrochloride) | 10 mg TabletAlu/Opaque White PVC Blister Pack x 10’s (Box of 100’s) | Rx | LIFESQUARE LABORATORIES INC.Philippines | ALMAN PHARMACEUTICALS, INC. | DRP-5185-08 | Mar 3, 2029 | |
LerifCetirizine Dihydrochloride | 2.5 mg / mL Syrup (Oral Drops)Boston Round Amber Bottle x 15 mL with Medicine Dropper Box of 1's | OTC | LifeSquare Laboratories, Inc.Philippines | Vispomed Enterprises | DRP-5508-05 | Feb 23, 2027 | |
LerifCetirizine Dihydrochloride | 5 mg/ 5 mL SyrupBoston Round Amber Bottle x 30 mL Box of 1's; Boston Round Amber Bottle x 60 mL Box of 1's | Rx | LifeSquare Laboratories, Inc.Philippines | Vispomed Enterprises | DRP-5405-02 | Feb 23, 2027 | |
LewizineCetirizine Dihydrochloride | 5 mg / 5 ml SyrupBoston Round Amber Bottle x 60 mL (Box of 1's); Boston Round Amber Bottle x 30mL (Box of 1's) | Rx | Lifesquare Laboratories Inc.Philippines | Lewison Pharmaceuticals Corporation | DRP-5405-08 | Feb 23, 2027 | |
LEXYRCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. TOLMANN LABORATORIES INC.Philippines | AUSPICIA INC. | DRP-5754-07 | Mar 12, 2029 | |
MedrizineCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 40's (Box of 40's and 120's); Alu/Clear PVC Blister Pack x 20's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | — | DRP-5427 | Aug 8, 2029 | |
MedrizineCetirizine Hydrochloride | 2.5mg/mL Syrup (Oral Drops) Grapes FlavorBoston Round Amber Glass Bottle x 10mL (Box of 1's) | OTC | AZARIAS PHARMACEUTICAL LABORATORIES INC.Philippines | — | DRP-4067 | Oct 19, 2027 | |
MedrizineCetirizine Hydrochloride | 5 mg/ 5 mL SyrupBoston Round Amber Glass Bottle x 60 mL (Box of 1's) | OTC | AZARIAS PHARMACEUTICAL LABORATORIES INC.Philippines | — | DRP-4105 | Nov 19, 2027 | |
MetirizineCetirizine Dihydrochloride | 10 mg TabletAlu/PVC Blister Pack x 10’s (Box of 100’s) | OTC | Umedica Laboratories Pvt. Ltd.India | RM Lorenzo Pharma & Distribution Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1182-06 | Dec 16, 2028 | |
New ZyrineCetirizine Hydrochloride | 5 mg/5 mL Oral Solution (Mint Flavor)Boston Round Pilfer Proof Finish Amber Glass Bottle with Metal Cap x 10 mL (as Physician's Sample) Boston Round Pilfer Proof Finish Amber Glass Bottle with Metal Cap x 30 mL and 60 mL | OTC | Scheele Laboratories Phils., Inc.Philippines | — | DRP-17097 | Sep 24, 2030 | |
NoneCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Sydler Remedies Pvt. LimitedIndia | Medethix,Inc. | DRP-11828 | May 6, 2031 | |
NoneCetirizine (as hydrochloride) | 10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's blister packs x 10 tablets) | OTC | Magbro Healthcare Pvt. Ltd.India | Alkem Laboratories CorporationImporter: Pharmakon Biotec Inc. | DRP-14046-01 | Jun 8, 2028 | |
NoneCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | OTC | Magbro Healthcare Pvt. Ltd.India | Miracare CorporationImporter: Teramedix Pharma Trading Inc. | DRP-14456-01 | Sep 8, 2028 | |
NoneCetirizine hydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Interphil Laboratories, Inc.Philippines | Rose Pharmacy, Inc. | DRP-1469-03 | Jan 31, 2028 | |
NoneCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Interphil Laboratories, Inc.Philippines | St. Joseph Drugstore | DRP-1469-08 | Jan 31, 2028 | |
NoneCetirizine hydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Interphil Laboratories, Inc.Philippines | South Star Drug | DRP-1469-09 | Jan 31, 2028 | |
NoneCetirizine | 10 mg Film-Coated TabletAlu/Foil Blister Pack x 10's (Box of 100's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Reta DrugImporter: Accesspoint International Trading Inc. | DRP-15601-02 | Aug 8, 2029 | |
NoneCetirizine (as Dihydrochloride) | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Mediwin PharmaceuticalsIndia | Actimed, Inc.Importer: Ambica International Corporation | DRP-4472-01 | Jun 13, 2028 | |
NoneCetirizine dihydrochloride | 10 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s and 100’s) | OTC | Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Limited)India | Ritemed Phils., Inc.Importer: Ambica International Corporation | DRP-6368 | Oct 2, 2030 | |
NoneCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/C1ear PVC Blister Pack x 10's (Box of 10's); Alu/C1ear PVC Blister Pack x 10's (Box of 30's) | OTC | PHIL. UNITED PHARMA CORPORATIONPhilippines | — | DRP-8085 | Feb 14, 2029 | |
NoneCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu-PVC Blister Pack x 10’s (Box of 30’s and 100’s) | OTC | Fredun Pharmaceuticals LimitedIndia | Roymed PharmaceuticalImporter: AMB HK Enterprises Inc. | DRP-8861-01 | May 18, 2031 | |
NoneCetirizine | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's, 50's & 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Eba Generisch Trading Inc. | DRP-16483-04 | Mar 25, 2030 | |
NoneCetirizine Dihydrochloride | 10 mg TabletPVC/Alu Blister Pack x 10's and 20's (Box of 100's) | OTC | Drugmaker's Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-262-04 | Jun 21, 2027 | |
NoneCetirizine Dihydrochloride | 10 mg TabletBlister Strip x 20's Box of 100's | OTC | Amherst Laboratories, Inc.Philippines | RiteMED Phils., Inc. | DRP-2677-02 | Aug 7, 2027 | |
NoneCetirizine dihydrochloride | 10 mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | OTC | XL Laboratories Pvt. Ltd.India | International Pharmaceuticals, Inc.Importer: Ambica International Corporation | DRP-3851-01 | Jul 1, 2030 | |
NoneCetirizine dihydrochloride | 10 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's) | OTC | XL Laboratories Pvt. Ltd.India | RiteMED Phils., Inc.Importer: Ambica International Corporation | DRP-3851-02 | Jul 1, 2030 | |
NoneCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Bewise Trading Corp. (Doing business under the name & style of Pharmaplus Generic & Branded Drug Distributor & Medical Supplies) | DRP-5427-08 | Aug 8, 2029 | |
NoneCetirizine Hydrochloride | 10 mg Tablet2 Composite packs of Alu/PVC Blister Pack of 5 x 10's (Box of 100's) | OTC | Stallion Laboratories Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-5546-01 | Sep 26, 2029 | |
NoneCetirizine Hydrochloride | 10 mg Tablet2 Composite packs of Alu/PVC Blister Pack of 5 x 10's (Box of 100's) | OTC | Stallion Laboratories Pvt. Ltd.India | Diafarm Inc.Importer: Ambica International Corporation | DRP-5546-03 | Sep 26, 2029 | |
NoneCetirizine Hydrochloride | 10 mg Tablet2 Composite packs of Alu/PVC Blister Pack of 5 x 10's (Box of 100's) | OTC | Stallion Laboratories Pvt. Ltd.India | Reta DrugImporter: Ambica International Corporation | DRP-5546-04 | Sep 26, 2029 | |
NoneCetirizine Hydrochloride | 10 mg TabletAlu-Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Stallion Laboratories Pvt. Ltd.India | Actimed, Inc.Importer: Ambica International Corporation | DRP-6260-03 | Jun 3, 2028 | |
NoneCetirizine Hydrochloride | 10 mg TabletAlu-Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Stallion Laboratories Pvt. Ltd.India | PharmaVital Corp.Importer: Ambica International Corporation | DRP-6260-06 | Jun 3, 2028 | |
NoneCetirizine Dihydrochloride | 10 mg TabletBlister Pack x 10's (Box of 100's) | OTC | HIZON LABORATORIES, INC.Philippines | Boie Incorporated | DRP-740-05 | Aug 30, 2027 | |
NoneCetirizine Hydrochloride | 10 mg/mL Syrup (Oral Drops)Amber Bottle x 10 mL (Box of 1's) | OTC | New Myrex Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-6811-01 | Feb 3, 2032 | |
NoneCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. TOLMANN LABORATORIES INC.Philippines | TGP PHARMA INC. | DRP-5754 | Mar 12, 2029 | |
NoneCetirizine Dihydrochloride | 2.5 mg/mL Syrup (Oral Drops)In a box of 1 Amber glass bottle x 10 mL | OTC | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY45910 | Jun 5, 2027 | |
NoneCetirizine | 5 mg / 5 mL Oral Solution (Apple Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Reta DrugImporter: Accesspoint International Trading Inc. | DRP-15602-01 | Aug 8, 2029 | |
NoneCetirizine Dihydrochloride | 5 mg /5 mL Oral SolutionAmber Glass Bottle x 60mL (Box of 1's) | OTC | Stallion Laboratories Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-10129-04 | Jul 29, 2031 | |
NoneCetirizine Dihydrochloride | 5 mg/5 mL Oral SolutionAmber Glass Bottle x 60mL (Box of 1's) | OTC | Stallion Laboratories Pvt. Ltd.India | PharmaVital Corp.Importer: Ambica International Corporation | DRP-10129-03 | Jul 29, 2031 | |
NoneCetirizine | 5 mg/5 mL Oral Solution (Grape Flavor)PET Amber Bottle with Light Orange ROPP Cap x 60 mL with 10 mL Measuring Cup Box of 1’s | Rx | Medley Pharmaceuticals LimitedIndia | Importer: Ambica International Corporation | DRP-9759 | May 28, 2031 | |
NoneCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle with White Aluminum Cap x 60 mL (Box of 1's) | OTC | Interphil Laboratories, Inc.Philippines | Icon Healthcare, Inc. | DRP-1468-02 | May 8, 2031 | |
NoneCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle with White Aluminum Cap x 60 mL (Box of 1's) | OTC | Interphil Laboratories, Inc.Philippines | Ritemed Phils., Inc. | DRP-1468-09 | Aug 18, 2031 | |
NoneCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle with White Aluminum Cap x 60 mL (Box of 1's) | OTC | Interphil Laboratories, Inc.Philippines | St. Joseph Drugstore | DRP-1468-11 | May 13, 2031 | |
NoneCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories IncPhilippines | Daily Grace Unlimited Inc | DRP-3522-04 | Feb 1, 2027 | |
NoneCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | BEWISE TRADING CORP. Doing business under the name & style of PHARMAPLUS GENERIC & BRANDED DRUG DISTRIBUTOR & MEDICAL SUPPLIES | DRP-3522-07 | Feb 1, 2027 | |
NoneCetirizine Hydrochloride | 5 mg/5 mL Syrup60 mL Amber Glass Bottle Box for 1's | OTC | XL Laboratories Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-3707-03 | Dec 21, 2029 | |
NoneCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle with Measuring Cap x 60 mL (Box of 1's) | OTC | XL Laboratories Pvt. Ltd.India | Diafarm Inc.Importer: Ambica International Corporation | DRP-3707-05 | Dec 21, 2029 | |
NoneCetirizine Dihydrochloride | 5 mg/5 mL Syrup60 mL Boston Round Amber Bottle sealed with white aluminum cap (Box of 1's) | OTC | Hizon Laboratories, Inc.Philippines | Actimed, Inc. | DRP-6229-01 | Jun 30, 2029 | |
NoneCetirizine Dihydrochloride | 5 mg/5 mL SyrupBoston Round Amber Bottle Sealed with White Aluminum Cap x 60 mL Box of 1's | OTC | Hizon Laboratories, Inc.Philippines | Rose Pharmacy, Incorporated | DRP-6229-02 | Jun 30, 2029 | |
NoneCetirizine Dihydrochloride | 5 mg/5 mL Syrup (Grape Flavor)Round PET Amber Bottle with HDPE Bottle Cap and 20 mL PET Measuring Cup x 60 mL, 120 mL and 250 mL (Box of 1’s) | OTC | Phil. United Pharma CorporationPhilippines | — | DRP-18834 | Sep 15, 2031 | |
NoneCetirizine Dihydrochloride | 5 mg/5 mL Syrup (Grape Flavor0Round Glass Amber Bottle with Foam-lined Aluminum Cap with PSP liner and 20 mL PET Measuring Cup x 60 mL, 120 mL and 250 mL (Box of 1’s) | OTC | Phil. United Pharma CorporationPhilippines | — | DRP-18835 | Sep 15, 2031 | |
NoneCetirizine Dihydrochloride | 5mg/5mL SyrupIn a box of 1 Amber glass bottle (30 mL; 60 mL) | OTC | Amherst Laboratories, Inc.Philippines | Trader: UNILAB, Inc. | DR-XY45911 | Jun 5, 2027 | |
NoneCetirizine Hydrochloride | 5mg/5mL SyrupAmber Bottle x 60mL (Box of 1's) | OTC | New Myrex Laboratories, Inc.Philippines | TGP Pharma, Inc. | DRP-6812-01 | Aug 26, 2031 | |
None (Reformulated)Cetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's); Alu/Clear PVC Blister Pack x 2's (Physician's sample) | OTC | Interphil Laboratories, Inc.Philippines | Neodrug, Inc. | DRP-1469-04 | Jan 31, 2028 | |
One-CetCetirizine Dihydrochloride | 5 mg/5 mL Syrup60 mL Boston Round Amber Bottle Box of 1's | OTC | Hizon Laboratories, Inc.Philippines | — | DR-XY43686 | Sep 3, 2029 | |
PharzinCetirizine (as hydrochloride) | 10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10 blister packs x 10 tablets) | Rx | Magbro Healthcare Pvt. Ltd.India | Pharmakon Biotec Inc. | DRP-14046 | Jun 8, 2028 | |
PillrizineCetirizine dihydrochloride | 10 mg/mL Solution (Oral Drops)Amber PET Bottle x 10 mL (Box of 1's) | OTC | Stallion Laboratories Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-9074-01 | Aug 17, 2030 | |
PrixlaeCetirizine Hydrochloride | 10 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | OTC | Shou Chan Industrial Co., Ltd.Taiwan | New Smart Formulae Trading Corp. | DR-XY29244 | Dec 11, 2028 | |
QualcetCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Unicure Remedies Pvt. Ltd.India | All-Bio Pharma, Inc.Importer: Ambica International Corporation | DRP-4360-01 | Apr 8, 2028 | |
QUALCETCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. TOLMANN LABORATORIES INC.Philippines | ALL-BIO PHARMA, INC. | DRP-5754-06 | Mar 12, 2029 | |
QualcetCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle with Measuring Cap x 60 mL (Box of 1's) | OTC | XL Laboratories Pvt. Ltd.India | All-Bio Pharma, Inc.Importer: Ambica International Corporation | DRP-3707-04 | Dec 21, 2029 | |
QualcetCetirizine Dihydrochloride | 5mg/5mL Oral SolutionAmber Glass Bottle x 60mL (Box of 1's) | OTC | Stallion Laboratories Pvt. Ltd.India | All-Bio Pharma, Inc.Importer: Ambica International Corporation | DRP-10129-01 | Aug 19, 2037 | |
ReaxCetirizine (as Dihydrochloride) | 10 mg TabletAlu/Opaque White PVC Blister Pack x 10’s (Box of 100’s) | Rx | Lifesquare Laboratories Inc.Philippines | — | DRP-5185 | Mar 3, 2029 | |
ReaxCetirizine Dihydrochloride | 2.5 mg/mL Syrup (Oral Drops)Boston Round Amber Bottle x 15 mL with medicine dropper (Box of 1's) | OTC | LifeSquare Laboratories Inc.Philippines | — | DRP-5508 | Feb 23, 2027 | |
ReaxCetirizine Dihydrochloride | 5 mg/5 mL SyrupBoston Round Amber Bottle x 60 mL (Box of 1's); Boston Round Amber Bottle x 30 mL (Box of 1's) | Rx | LifeSquare Laboratories Inc.Philippines | — | DRP-5405 | Feb 23, 2027 | |
RegicetCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu-PVC Blister Pack x 10’s (Box of 30’s and 100’s) | OTC | Fredun Pharmaceuticals LimitedIndia | Regimed Pharmaceutical DistributorImporter: Philrx Pharma Inc. | DRP-8861-04 | May 18, 2031 | |
RegicetCetirizine Hydrochloride | 5 mg/5 mL Oral SolutionAmber glass bottle x 60 mL (Box of 1's) | OTC | Scheele Laboratories Phil., Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-1352-04 | Apr 13, 2029 | |
RegizineCetirizine | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's, 50's & 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-16483-02 | Mar 25, 2030 | |
RegizineCetirizine Hydrochloride | 5mg/5mL SyrupAmber Bottle x 60mL (Box of 1's) | OTC | New Myrex Laboratories, Inc.Bulacan | Regimed Pharmaceutical Distributor | DRP-6812-02 | Aug 26, 2031 | |
Regizine ODCetirizine Hydrochloride | 2.5mg/mL Syrup (Oral Drops)Boston Round Amber Bottle x 15mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-3987-06 | Sep 13, 2027 | |
Regizine-SCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-3522-15 | Feb 1, 2027 | |
RetanixCetirizine dihydrochloride | 10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100’s) | Rx | Akriti Pharmaceuticals Pvt. Ltd.India | Reta DrugImporter: AGlobal Care, Inc. | DRP-11128-04 | Sep 29, 2031 | |
Retanix-RCetirizine Dihydrochloride | 10 mg TabletAlu/PVC Blister Pack x 10’s (Box of 100’s) | OTC | Umedica Laboratories Pvt. Ltd.India | Reta DrugImporter: Suhitas Pharmaceuticals Inc. | DRP-1182-07 | Dec 16, 2028 | |
RetanyxCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | ACME Formulation Pvt. Ltd.India | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-8727-09 | Mar 2, 2031 | |
RextizineCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/ Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Next Wave (India)India | Aarex Pharma Distributor | DRP-11737 | May 17, 2027 | |
Rextizine-DCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu/ Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Next Wave (India)India | Aarex Pharma Distributor | DRP-11738 | May 17, 2027 | |
Rhegium- ZCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | Acme Formulation Pvt. Ltd.India | Rhegium Health Trade PharmaImporter: Medinova Pharmaceutical Inc. | DRP-8727-10 | Feb 12, 2030 | |
RhinilCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu PVC Blister Pack x 10's (Box of 100's) | Rx | Aristopharma Ltd.Bangladesh | Sahar International Trading, Inc.Importer: Sahar international Trading, Inc. | DR-XY44343 | Mar 19, 2030 | |
Rhinisaph-10Cetirizine Dihydrochloride | 10 mg/mL Syrup (Oral Drops)PET Round Amber Bottle with White HDPE Cap x 10 mL, 15 mL and 30 mL with Plastic Dropper (Box of 1's) | Rx | Sapphire Lifesciences Pvt. LtdIndia | Nelpa Lifesciences, Inc. | DRP-9425 | Dec 19, 2030 | |
Rhinisaph-5Cetirizine dihydrochloride | 5 mg/5 mL Syrup (Melon Flavor)PET Round Amber Bottle with White HDPE Cap x 60 mL and 120 mL (Box of 1's) | OTC | Enicar Pharmaceutical Pvt. Ltd.India | Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-9293 | Oct 23, 2030 | |
RhinitrinCetirizine (as hydrochloride) | 5 mg/5 mL SyrupType III Amber Glass Bottle x 10 mL, 30 mL and 60 mL (Box of 1's) | Rx | Scheele Laboratories Phils., Inc.Philippines | Trader: Remed Pharmaceuticals, Inc. | DRP-1782 | Dec 29, 2029 | |
RICAMCetirizine Hydrochloride | 10 mg Tablet | OTC | HOVID BERHAD | — | DRP-6916 | Feb 13, 2027 | |
RicamCetirizine Hydrochloride | 10mg TabletPVDC/Alu Blister pack x 10's (Box of 100's) | OTC | Hovid Bhd.Malaysia | Hovid Inc. | DRP-12947 | Nov 8, 2027 | |
RicamCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Polyethylene Terephthalate Bottle x 60 mL (Box of 1's) | OTC | Hovid BerhadMalaysia | Importer: Hovid Inc | DR-XY46698 | Sep 11, 2029 | |
RinozineCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Pharmasant Laboratories Co., Ltd.Thailand | Endure Medical, Inc. | DR-XY40836 | Apr 19, 2027 | |
RizinCetirizine dihydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 100’s) | Rx | Samjin Pharmaceutical Co., Ltd.Republic of Korea | D & G PharmaImporter: Unimex, Inc. | DR-XY30857 | Mar 13, 2031 | |
RizippexCetirizine Hydrochloride | 2.5 mg/mL Syrup (Oral Drops)Boston Round Amber Bottle x 15 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Appex MD's Pharmaceuticals Inc. | DRP-3987-01 | Sep 13, 2027 | |
RyvelCetirizine hydrochloride | 1 mg/mL (5 mg/5 mL) SyrupAmber Glass Bottle x 60 mL with plastic spoon in a box | OTC | PT. Novell Pharmaceutical LaboratoriesIndonesia | Prosweal Healthcare Inc. | DR-XY46436 | Oct 16, 2028 | |
RyvelCetirizine | 10 mg Film-coated TabletPVC/PVDC Blister Pack x 10's (Box of 30's) | OTC | PT. Novell Pharmaceutical LaboratoriesIndonesia | Prosweal Healthcare Inc | DR-XY49368 | Apr 2, 2030 | |
SaphzineCetirizine (as Hydrochloride) | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | SAPPHIRE LIFESCIENCES PVT. LTDIndia | NELPA LIFESCIENCES, INC. | DRP-5176 | Feb 27, 2029 | |
Saphzine-10Cetirizine dihydrochloride | 10 mg/mL Syrup (Oral Drops)PET Round Amber Bottle with White HDPE Cap x 10 mL,15 mL, and 30 mL with Plastic Dropper (Box of 1's) | Rx | Azine Healthcare Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd | DRP-9379 | Dec 15, 2030 | |
Saphzine-5Cetirizine Dihydrochloride | 5 mg/5 mL SyrupPet Round Amber Bottle With Ropp Cap X 60 mL & 120 mL (Box of 1's) | OTC | Genom Biotech Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-9216 | Sep 15, 2031 | |
Saphzine-ODCetirizine Dihydrochloride | 2.5 mg/mL Syrup (Oral Drops)Pet Round Amber Bottle With White ROPP Cap X 15 mL And 30 mL with Plastic Dropper (Box of 1's) | OTC | Genom Biotech Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-9215 | Sep 15, 2031 | |
SelergyCetirizine Dihydrochloride | 2.5 mg / mL Syrup (Oral Drops)Boston Round Amber Bottle x 15 mL with Medicine Dropper (Box of 1's) | OTC | LifeSquare Laboratories, Inc.Philippines | SEAMMED PHARMA | DRP-5508-07 | Feb 23, 2027 | |
SelergyCetirizine Dihydrochloride | 5 mg / 5 mL SyrupBoston Round Amber Bottle x 60 mL Box of 1's | Rx | LifeSquare Laboratories, Inc.Philippines | Seammed Pharma | DRP-5405-09 | Feb 23, 2027 | |
Seth-RineCetirizine Hydrochloride | 5 mg / 5 mL Oral SolutionAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Scheele Laboratories Phils., Inc.Philippines | 999 Seth Pharmaceutical Inc. | DRP-1352-06 | Apr 13, 2029 | |
SherizineCetirizine (as hydrochloride) | 10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10 blister packs x 10 tablets) | OTC | Magbro Healthcare Pvt. Ltd.India | Kain's Trading Corp.Importer: Pharmakon Biotec Inc. | DRP-14046-03 | Jun 8, 2028 | |
SimtecCetirizine Hydrochloride | 10mg TabletPVDC Blister Pack x 10's (Box of 500's) | OTC | Duopharma Manufacturing (Bangi) Sdn. Bhd.Malaysia | Importer: DB (Philippines), Inc. | DR-XY48304 | Aug 19, 2027 | |
SitrizineCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's Box of 100's | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | STARPHARM, INC. | DRP-5427-04 | Aug 8, 2029 | |
SitrizineCetirizine Hydrochloride | 2.5 mg/mL Syrup (Oral Drops)Boston Round Amber Glass Bottle x 10 mL (Box of 1's) | OTC | AZARIAS PHARMACEUTICAL LABORATORIES INC.Philippines | STARPHARM, INC. | DRP-4067-03 | Oct 19, 2027 | |
SitrizineCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | Starpharm, Inc. | DRP-3522-03 | Feb 1, 2027 | |
SoothlerCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's) | OTC | PSA Chemicals & Pharmaceuticals Pvt. Ltd.India | Suhitas Pharmaceuticals Inc. | DRP-16740 | Jul 4, 2030 | |
SyreliefCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Sydenham Laboratories, IncPhilippines | — | DRP-2058 | Sep 10, 2029 | |
TemprazinCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle with White Aluminum Cap x 30 mL and 60mL (Box of 1's); Amber Glass Bottle with White Aluminum Cap x 10 mL as Physician's Sample (Box of 1's) | OTC | Interphil Laboratories, Inc.Philippines | Taisho Pharmaceuticals (Philippines), Inc. | DRP-1468-05 | May 8, 2031 | |
TracenCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Syncom Formulations (India) LimitedIndia | Arvincare Pharma Inc. | DRP-3139 | Jul 27, 2028 | |
TrinxCetirizine | 10 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's, 50's & 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-16483-03 | Mar 25, 2030 | |
TrixsuerCetirizine Hydrochloride | 10 mg Film-Coated TabletBlister Pack x 10’s (Box of 100’s) | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-4744 | Jan 28, 2028 | |
Trizin 5Cetirizine dihydrochloride | 5 mg/mL SyrupPET Amber Bottle in 60 mL (Box of 1's) | OTC | Sakar Healthcare Pvt. Ltd.India | Euroasia Pharmaceuticals, Inc. | DR-XY44250 | Feb 27, 2030 | |
UnbrandedCetirizine Dihydrochloride | 10 mg Film-Coated Tablet | OTC | Zim Laboratories Ltd. | — | DRP-3689-01 | Mar 27, 2027 | |
UnbrandedCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Zim Laboratories Ltd.India | Airlife International Trading CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3689-03 | Mar 27, 2032 | |
UnbrandedCetirizine Dihydrochloride | 10 mg Film-Coated TabletBlister Pack x 10's (Box of 100's) | OTC | Lloyd Laboratories, Inc.Malolos Bulacan | Gamot Philippines, Inc.Trader: Euro-Health Care Exponents, Inc. | DRP-920-06 | Mar 14, 2032 | |
UnbrandedCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Coloured Glass Bottle with Measuring Cup x 60 mL Box of 1's | OTC | XL Laboratories Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-3707-01 | Dec 21, 2029 | |
UnbrandedCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle with Measuring Cap x 60 mL (Box of 1's) | OTC | XL Laboratories Pvt. Ltd.India | Actimed, Inc.Importer: Ambica International Corporation | DRP-3707-02 | Dec 21, 2029 | |
UnbrandedCetirizine Hydrochloride | 5mg/5mL Oral Solution (Orange Flavor)Amber Polyethylene Terephthalate (PET) Bottle with Measuring Cup x 60mL (Box of 1's) | OTC | XL Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-11071 | Jan 24, 2032 | |
VirilexCetirizine dihydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 100’s) | Rx | Hebei Tiancheng Pharmaceutical Co., Ltd.China | AMB HK Enterprises Inc. | DRP-9024 | Aug 4, 2031 | |
VirlixCetirizine Dihydrochloride | 1 mg/mL Oral SolutionAmber Glass Bottle x 30 mL (Box of 1's); Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Aesica Pharmaceuticals S.R.L.Italy | GlaxoSmithKline Philippines, Inc. | DR-XY23546 | Nov 17, 2029 | |
VirlixCetirizine Dihydrochloride | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 50's) | OTC | UCB Farchim SASwitzerland | GlaxoSmithKline Philippines, Inc. | DR-XY13333 | Nov 17, 2029 | |
VirlixCetirizine Dihydrochloride | 10 mg/mL Solution (Oral Drops)10 mL Amber Glass Bottle, Type III (EP) with LDPE Dropper and White PP Child-Proof Cap | OTC | Aesica Pharmaceuticals S.R.L.Italy | Importer: GlaxoSmithKline Philippines, Inc. | DR-XY16259 | Mar 24, 2029 | |
VIRTEXCETIRIZINE DIHYDROCHLORIDE | 10 mg Film-Coated Tablet | Rx | MEDICA KOREA CO., LTD | ENDURE MEDICAL, INC. | DR-XY32760 | Dec 18, 2026 | |
VirzineCetirizine Hydrochloride | 10 mg TabletPVC/Alu Blister Pack x 10's (Box of 100's) | OTC | Scheele Laboratories, Phils., Inc.Philippines | Jickstar Pharma Inc. | DRP-1353-01 | Apr 13, 2029 | |
WelcetCetirizine dihydrochloride | 5 mg/5 mL SyrupAmber Bottle x 60 mL (Box of 1's) | Rx | The Madras PharmaceuticalsIndia | Ambica International CorporationTrader: Unichem Laboratories Limited | DRP-6462 | Sep 29, 2031 | |
XirizinCetirizine Dihydrochloride | 10 mg Film-Coated TabletAlu-PVC Blister Pack x 10’s (Box of 100’s) | OTC | 4Care Lifescience Private LimitedIndia | Aglobal Care, Inc. | DRP-18142 | May 13, 2031 | |
ZebzineCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | OTC | ACME Formulation Pvt. Ltd.India | Zebe TradingImporter: Medinova Pharmaceutical Inc. | DRP-8727-06 | Feb 20, 2031 | |
ZericinCetirizine Dihydrochloride | 10 mg TabletBlister Pack x 10's Box of 100's | OTC | Hizon Laboratories, Inc.Philippines | Pharma Dynamic, Inc. | DRP-740-03 | Aug 30, 2027 | |
ZetirCetirizine Dihydrochloride | 10 mg TabletAlu/PVC Blister Pack x 10’s (Box of 100’s) | OTC | Umedica Laboratories Pvt. Ltd.India | Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1182-01 | Dec 16, 2028 | |
Zetri-AidCetirizine Dihydrochloride | 2.5 mg/mL Syrup (Oral Drops) (Grape Flavor)PET Amber Bottle x 10 mL (Box of 1’s) | OTC | Primecare Lifesciences Laboratories Corp.Philippines | Life and Health Source Pharmaceutical Distribution Co. | DRP-18786 | Sep 7, 2031 | |
Zetri-AidCetirizine Dihydrochloride | 5mg/5mL Syrup (Green Apple Flavor)PET Amber Bottle x 60 mL (Box of 1’s) | OTC | Primecare Lifesciences Laboratories Corp.Philippines | Life and Health Source Pharmaceutical Distribution Co. | DRP-18785 | Sep 7, 2031 | |
ZetrimedCetirizine (As Hydrochloride) | 10 mg TabletAlu-PVC Blister Pack x 10's (Box of 100's) | OTC | Ratnatris Pharmaceutical Pvt. Ltd.India | MEDINOVA PHARMACEUTICAL INC. | DRP-8451 | Oct 9, 2029 | |
ZetrineCetirizine Dihydrochloride | 1 mg/mL Oral SolutionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Euro-Health Care Exponents, Inc. | DRP-1317-04 | May 4, 2027 | |
ZetrinxCetirizine Hydrochloride | 10 mg TabletAlu/Clear PVC Blister Pack x 20's (Box of 100's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-5427-02 | Aug 8, 2029 | |
ZetrinxCetirizine Hydrochloride | 2.5 mg/mL Syrup (Oral Drops)Boston Round Amber Glass Bottle x 10 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-4067-01 | Oct 19, 2027 | |
ZetrinxCetirizine Hydrochloride | 5 mg/5mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-3522-08 | Feb 1, 2027 | |
ZetrizCetirizine Dihydrochloride | 10 mg TabletPVC/Alu Blister Pack x 10's and 20's (Box of 100's) | OTC | Drugmaker's Laboratories, Inc.Philippines | — | DRP-262 | Jun 21, 2027 | |
ZetrizCetirizine Dihydrochloride | 10 mg/mL Oral Drops SolutionAmber Boston Bottle x 15 mL (Box of 1's) | Rx | Drugmaker's Laboratories Inc.Philippines | — | DRP-8277 | Jul 29, 2031 | |
ZetrizCetirizine Dihydrochloride | 2.5 mg/mL Syrup (Oral Drops)Type III Boston Amber Bottle with plain metal cap and dropper x 10 mL and 15 mL (Box of 1's) | OTC | Drugmaker's Laboratories, Inc.Philippines | — | DRP-9228 | Oct 13, 2027 | |
ZetrizCetirizine (as hydrochloride) | 5mg/5mL Syrup (Apple Flavor)Amber Bottle with metal cap x 60 mL (Box of 1's) | OTC | Drugmaker's Laboratories, Inc.Philippines | — | DRP-14754 | Jan 3, 2029 | |
ZincetCetirizine Dihydrochloride | 1 mg/mL Oral SolutionAmber Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Bulacan | Basic Pharmaceutical CorporationTrader: Euro-Health Care Exponents, Inc. | DRP-1317-07 | May 4, 2032 | |
ZincetCetirizine Dihydrochloride | 10 mg Film-Coated TabletBlister Pack x 20's (Box of 100's) | OTC | Lloyd Laboratories, Inc.Malolos Bulacan | Basic Pharmaceutical CorporationTrader: Euro-Health Care Exponents, Inc | DRP-920-05 | Mar 14, 2037 | |
ZinegoldCetirizine Hydrochloride | 10 mg TabletAlu-Clear PVC Blister Pack x 10's (Box of 30's and 100's) | OTC | Stallion Laboratories Pvt. Ltd.India | JVZEA Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-6260-02 | Jun 3, 2028 | |
Zinesaph-10Cetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 30’s and 100’s) | OTC | Sai Parenterals Ltd.India | Nelpa Lifesciences, Inc. | DRP-18141 | May 13, 2031 | |
ZinevexCetirizine Hydrochloride | 10 mg Film Coated TabletAlu PVC Blister Pack x 10's (Box of 100's) | OTC | Pelltech Health Care Private Ltd.India | Sannovex Pharmaceutical Distributor | DRP-16659 | May 30, 2030 | |
ZinexCetirizine Hydrochloride | 1 mg/mL (5 mg/5 mL) SyrupAmber colored PET Bottle x 30 mL and 60 mL Box of 1's | Rx | Rhydburg Pharmaceuticals Ltd.India | IBERICA VERHEILEN PHARMACEUTICALS GROUP CORP.Importer: VERHEILEN IBERICA HEALTH CARE COMPANY INC.Trader: Verheilen Pharmaceuticals GmbH | DR-XY42931 | Nov 13, 2028 | |
ZinexCetirizine Hydrochloride | 10 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Emil Pharmaceutical Industries Pvt. Ltd.India | Verheilen Iberica Health Care Company Inc.Trader: Farma Iberica S.L. | DRP-674 | Oct 2, 2027 | |
ZintreneCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. Tolmann Laboratories, Inc.Philippines | Aisec Farma Corporation | DRP-5754-03 | Mar 12, 2029 | |
ZintreneCetirizine Dihydrochloride | 5mg/5mL Oral SolutionAmber Glass Bottle x 60mL (Box of 1's) | OTC | Stallion Laboratories Pvt. Ltd.India | Aisec Farma CorporationImporter: Ambica International Corporation | DRP-10129-02 | Feb 4, 2032 | |
Zintrene 10Cetirizine dihydrochloride | 10 mg/mL Solution (Oral Drops)Amber PET Bottle x 10 mL (Box of 1's) | OTC | Stallion Laboratories Pvt. Ltd.India | Aisec Farma CorporationImporter: Ambica International Corporation | DRP-9074-02 | Aug 17, 2030 | |
ZinvecCetirizine hydrochloride | 10 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Bal Pharma LimitedIndia | Endure Medical, Inc.Importer: Singapore Genebio, Inc. | DR-XY42320 | Nov 6, 2027 | |
ZiridimCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle with Measuring Cup x 60 mL Box of 1's | OTC | XL Laboratories Pvt. Ltd.India | Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation | DRP-3707-06 | Dec 21, 2029 | |
ZirimaxCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's) | OTC | Unison Pharmaceuticals Pvt. Ltd.India | Dreamax Incorporated | DRP-17329 | Nov 18, 2030 | |
ZirtrixxCetirizine Hydrochloride | 5 mg / 5 mL Oral SolutionAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Scheele Laboratories Phils., Inc.Philippines | Bio Erixx Pharma Distribution | DRP-1352-07 | Apr 13, 2029 | |
ZydrixCetirizine | 10 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Sydler Remedies Pvt. LimitedIndia | Medethix, Inc. | DRP-14364 | Sep 5, 2031 | |
ZykemCetirizine Hydrochloride | 5 mg/5 mL Oral SolutionAmber PET Bottle x 30's and 60's (Box of 1's) | OTC | Rhydburg Pharmaceuticals Ltd.India | Alkem Laboratories Corporation | DRP-9947 | Jun 29, 2031 | |
ZynirixCetirizine Dihydrochloride | 2.5 mg/mL Suspension (Oral Drops) (Lemon Flavor)15 mL Capacity Boston Round Amber Glass Bottle with Medicine Dropper x 10 mL (Box of 1's) | OTC | J.M. Tolmann Laboratories, Inc.Philippines | Westfield Pharmaceuticals, Inc. | DRP-5754-14 | Mar 12, 2029 | |
ZynixCetirizine Hydrochloride | 5 mg/5 mL Syrup (Raspberry Flavor)PET Round Amber Bottle x 60 mL (Box of 1’s) | OTC | Scott-Edil Pharmacia Limited (Unit II)II)India | Greencore Pharma Inc. | DRP-18702 | Aug 25, 2031 | |
ZyrelixCetirizine Dihydrochloride | 2.5 mg/mL Syrup (Oral Drops) (Grape Flavor) | OTC | Jiangxi Xierkangtai Pharmaceutical Co., Ltd.China | PhilRx Pharma Inc. | DRP-17654 | Feb 18, 2031 | |
ZyrelixCetirizine Dihydrochloride | 5 mg/5 mL Syrup (Grape FlavorAmber Glass Bottle x 30 mL & 60 mL (Box of 1's) | OTC | Jiangxi Xierkangtai Pharmaceutical Co., LtdChina | PhilRx Pharma Inc. | DRP-17623 | Feb 10, 2031 | |
ZyrineCetirizine Hydrochloride | 10 mg TabletPVC/Alu Blister Pack x 10's (Box of 100's) | OTC | Scheele Laboratories Phils., Inc.Philippines | — | DRP-1353 | Apr 13, 2029 | |
ZyrineCetirizine Hydrochloride | 5 mg/5 mL Oral SolutionAmber Glass Bottle x 30 mL, 60 mL and 10 mL (Physician's sample) (Box of 1's) | OTC | Scheele Laboratories Phils., Inc.Philippines | — | DRP-1352 | Apr 13, 2029 | |
ZyrizCetirizine Hydrochloride | 10 mg Film Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's) | OTC | Interphil Laboratories, Inc.Philippines | The Cathay YSS Distributors Co., Inc. | DRP-1469-07 | Jan 31, 2028 | |
ZyrizCetirizine Hydrochloride | 5 mg/5 mL SyrupAmber Glass Bottle with White Aluminum Cap x 60 mL and 10 mL (Physician's Sample) (Box of 1's) | OTC | Interphil Laboratories Inc.Philippines | The Cathay YSS Distributors Co., Inc | DRP-1468-10 | May 20, 2031 | |
ZyrriginCetirizine Hydrochloride | 1 mg/mL (5 mg/5 mL) SyrupPolyethylene (PE) Opaque White Bottle x 60 mL (Box of 1's) | Rx | Unison Laboratories Co., Ltd.Thailand | JustRight Healthcare Inc. | DR-XY31796 | Jan 25, 2029 | |
ZyrriginCetirizine Dihydrochloride | 10 mg Film Coated TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 100's) | Rx | Unison Laboratories Co., Ltd.Thailand | JustRight Healthcare Inc. | DR-XY29378 | Feb 26, 2032 | |
ZytrexCetirizine Hydrochloride | 10 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 30’s and 100’s) | Rx | Hebei Tiancheng Pharmaceutical Co., Ltd.China | AMB HK Enterprises Inc. | DRP-8882 | May 27, 2031 | |
(no brand name)Cetirizine Hydrochloride | 10 mg TabletAlu/PVC Clear Blister Pack x 10's (Box of 100's) | OTC | Wintech Pharmaceuticals Ltd.India | The Rap Rite Aid Pharmaceutical Corp. | DRP-14443 | Sep 6, 2028 | |
(no brand name)Cetirizine hydrochloride | 5 mg/5 mL Oral SolutionAmber PET Bottle x 30 mL (Box of 1's) | OTC | Rhydburg Pharmaceuticals Limited.India | Genedrift Philippines OPCTrader: BSD Global Pte Ltd. | DRP-15304 | Jun 13, 2029 | |
(no brand name)Cetirizine | 5 mg/5 mL SyrupAmber PET Bottle x 30mL and 60mL (Box of 1's) | OTC | Rhydburg Pharmaceuticals LimitedIndia | Importer: Khriz Pharma Trading Inc. | DRP-11267 | Feb 21, 2027 | |
(no brand name)Cetirizine | 5mg/5mL Oral Solution (Apple Flavor)Amber PET Bottle x 60 mL (Box of 1's) | OTC | Opal Laboratories (Pvt.) Ltd.Pakistan | Accesspoint International Trading | DRP-15602 | May 12, 2031 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
PRECAUTIONS Activities Requiring Mental Alertness: In clinical trials, the occurrence of somnolence has been reported in some patients taking cetirizine hydrochloride; due caution should therefore be exercised when driving a car or operating potentially dangerous machinery. Concurrent use of cetirizine hydrochloride with alcohol or other CNS depressants should be avoided because additional reductions in alertness and additional impairment of CNS performance may occur.
Risk of New Onset Pruritus After Discontinuation of Cetirizine: Cases of pruritus after discontinuation of cetirizine have been reported in the postmarketing setting in patients where pruritus was not present before initiation of cetirizine. Pruritus occurred within a few days of discontinuing cetirizine among patients who used cetirizine long-term (e.g., few months to years).
Reported cases of pruritus were infrequent, but some were serious with patients experiencing widespread severe pruritus. If pruritus occurs after discontinuation of cetirizine, symptoms may improve with restarting or tapering cetirizine. Drug-Drug Interactions: No clinically significant drug interactions have been found with theophylline at a low dose, azithromycin, pseudoephedrine, ketoconazole, or erythromycin.
There was a small decrease in the clearance of cetirizine caused by a 400-mg dose of theophylline; it is possible that larger theophylline doses could have a greater effect. Carcinogenesis, Mutagenesis and Impairment of Fertility: In a 2-year carcinogenicity study in rats, cetirizine was not carcinogenic at dietary doses up to 20 mg/kg (approximately 15 times the maximum recommended daily oral dose in adults on a mg/m 2 basis, or approximately 7 times the maximum recommended daily oral dose in infants on a mg/m 2 basis).
In a 2-year carcinogenicity study in mice, cetirizine caused an increased incidence of benign liver tumors in males at a dietary dose of 16 mg/kg (approximately 6 times the maximum recommended daily oral dose in adults on a mg/m 2 basis, or approximately 3 times the maximum recommended daily oral dose in infants on a mg/m 2 basis). No increase in the incidence of liver tumors was observed in mice at a dietary dose of 4 mg/kg (approximately 2 times the maximum recommended daily oral dose in adults on a mg/ 2 basis, or approximately equivalent to the maximum recommended daily oral dose in infants on a mg/m 2 basis).
The clinical significance of these findings during long-term use of cetirizine hydrochloride is not known. Cetirizine was not mutagenic in the Ames test, and not clastogenic in the human lymphocyte assay, the mouse lymphoma assay, and in vivo micronucleus test in rats. In a fertility and general reproductive performance study in mice, cetirizine did not impair fertility at an oral dose of 64 mg/kg (approximately 25 times the maximum recommended daily oral dose in adults on a mg/m 2 basis).
Pediatric Use: The safety of cetirizine hydrochloride has been demonstrated in pediatric patients aged 6 months to 5 years. The safety of cetirizine has been demonstrated in 168 patients aged 2 to 5 years in placebo-controlled trials of up to 4 weeks duration. On a mg/kg basis, most of the 168 patients received between 0.2 and 0.4 mg/kg of cetirizine HCl.
The safety of cetirizine in 399 patients aged 12 to 24 months has been demonstrated in a placebo-controlled 18-month trial, in which the average dose was 0.25 mg/kg bid, corresponding to a range of 4 to 11 mg/day. The safety of cetirizine hydrochloride oral solution has been demonstrated in 42 patients aged 6 to 11 months in a placebo controlled 7-day trial.
The prescribed dose was 0.25 mg/kg bid, which corresponded to a mean of 4.5 mg/day, with a range of 3.4 to 6.2 mg/day. The effectiveness of cetirizine hydrochloride for the treatment of allergic rhinitis and chronic idiopathic urticaria in pediatric patients aged 6 months to 5 years is based on an extrapolation of the demonstrated efficacy of cetirizine hydrochloride in adults with these conditions and the likelihood that the disease course, pathophysiology and the drug’s effect are substantially similar between these two populations.
Efficacy is extrapolated down to 6 months of age for perennial allergic rhinitis because this disease is thought to occur down to these ages in children. The recommended doses for the pediatric population are based on cross-study comparisons of the pharmacokinetics and pharmacodynamics of cetirizine in adult and pediatric subjects and on the safety profile of cetirizine in both adult and pediatric patients at doses equal to or higher than the recommended doses.
The cetirizine AUC and C max in pediatric subjects aged 6 to 23 months who received a mean of 2.3 mg in a single dose and in subjects aged 2 to 5 years who received a single dose of 5 mg of cetirizine oral solution was estimated to be intermediate between that observed in adults who received a single dose of 10 mg of cetirizine tablets and those who received a single dose of 20 mg of cetirizine tablets. The safety and effectiveness of cetirizine in pediatric patients under the age of 6 months have not been established.
Adverse reactions
Adverse reactions (US label) US FDA label
ADVERSE REACTIONS Pediatric studies were conducted with cetirizine hydrochloride. More than 1300 pediatric patients aged 6 to 11 years with more than 900 treated with cetirizine hydrochloride at doses of 1.25 to 10 mg per day were included in controlled and uncontrolled clinical trials conducted in the United States. The duration of treatment ranged from 2 to 12 weeks.
Placebo-controlled trials up to 4 weeks duration included 168 pediatric patients aged 2 to 5 years who received cetirizine, the majority of whom received single daily doses of 5 mg. A placebo-controlled trial 18 months in duration included 399 patients aged 12 to 24 months treated with cetirizine (0.25 mg/kg bid), and another placebo- controlled trial of 7 days duration included 42 patients aged 6 to 11 months who were treated with cetirizine (0.25 mg/kg bid).
The majority of adverse reactions reported in pediatric patients aged 2 to 11 years with cetirizine hydrochloride were mild or moderate. In placebo-controlled trials, the incidence of discontinuations due to adverse reactions in pediatric patients receiving up to 10 mg of cetirizine hydrochloride was uncommon (0.4% on cetirizine hydrochloride vs. 1.0% on placebo).
Table 1 lists adverse experiences which were reported for cetirizine hydrochloride 5 and 10 mg in pediatric patients aged 6 to 11 years in placebo-controlled clinical trials in the United States and were more common with cetirizine hydrochloride than placebo. Of these, abdominal pain was considered treatment-related and somnolence appeared to be dose-related, 1.3% in placebo, 1.9% at 5 mg and 4.2% at 10 mg.
The adverse experiences reported in pediatric patients aged 2 to 5 years in placebo-controlled trials were qualitatively similar in nature and generally similar in frequency to those reported in trials with children aged 6 to 11 years. In the placebo-controlled trials of pediatric patients 6 to 24 months of age, the incidences of adverse experiences, were similar in the cetirizine and placebo treatment groups in each study.
Somnolence occurred with essentially the same frequency in patients who received cetirizine and patients who received placebo. In a study of 1 week duration in children 6-11 months of age, patients who received cetirizine exhibited greater irritability/fussiness than patients on placebo. In a study of 18 months duration in patients 12 months and older, insomnia occurred more frequently in patients who received cetirizine compared to patients who received placebo (9.0% v. 5.3%).
In those patients who received 5 mg or more per day of cetirizine as compared to patients who received placebo, fatigue (3.6% v. 1.3%) and malaise (3.6% v. 1.8%) occurred more frequently. Table 1. Adverse Experiences Reported in Pediatric Patients Aged 6 to 11 Years in Placebo-Controlled United States Cetirizine Hydrochloride Trials (5 or 10 mg Dose) Which Occurred at a Frequency of ≥2% in Either the 5-mg or the 10- mg Cetirizine Hydrochloride Group, and More Frequently Than in the Placebo Group Adverse Experiences Placebo (N=309) Cetirizine hydrochloride 5 mg (N=161) 10 mg (N=215) Headache 12.3% 11.0% 14.0% Pharyngitis 2.9% 6.2% 2.8% Abdominal pain 1.9% 4.4% 5.6% Coughing 3.9% 4.4% 2.8% Somnolence 1.3% 1.9% 4.2% Diarrhea 1.3% 3.1% 1.9% Epistaxis 2.9% 3.7% 1.9% Bronchospasm 1.9% 3.1% 1.9% Nausea 1.9% 1.9% 2.8% Vomiting 1.0% 2.5% 2.3% The following events were observed infrequently (less than 2%), in either 3982 adults and children 12 years and older or in 659 pediatric patients aged 6 to 11 years who received cetirizine hydrochloride in U.S. trials, including an open adult study of six months duration.
A causal relationship of these infrequent events with cetirizine hydrochloride administration has not been established. Autonomic Nervous System: anorexia, flushing, increased salivation, urinary retention. Cardiovascular: cardiac failure, hypertension, palpitation, tachycardia. Central and Peripheral Nervous Systems: abnormal coordination, ataxia, confusion, dysphonia, hyperesthesia, hyperkinesia, hypertonia, hypoesthesia, leg cramps, migraine, myelitis, paralysis, paresthesia, ptosis, syncope, tremor, twitching, vertigo, visual field defect.
Gastrointestinal: abnormal hepatic function, aggravated tooth caries, constipation, dyspepsia, eructation, flatulence, gastritis, hemorrhoids, increased appetite, melena, rectal hemorrhage, stomatitis including ulcerative stomatitis, tongue discoloration, tongue edema. Genitourinary: cystitis, dysuria, hematuria, micturition frequency, polyuria, urinary incontinence, urinary tract infection.
Hearing and Vestibular: deafness, earache, ototoxicity, tinnitus. Metabolic/Nutritional: dehydration, diabetes mellitus, thirst. Musculoskeletal: arthralgia, arthritis, arthrosis, muscle weakness, myalgia. Psychiatric: abnormal thinking, agitation, amnesia, anxiety, decreased libido, depersonalization, depression, emotional lability, euphoria, impaired concentration, insomnia, nervousness, paroniria, sleep disorder.
Respiratory System: bronchitis, dyspnea, hyperventilation, increased sputum, pneumonia, respiratory disorder, rhinitis, sinusitis, upper respiratory tract infection. Reproductive: dysmenorrhea, female breast pain, intermenstrual bleeding, leukorrhea, menorrhagia, vaginitis. Reticuloendothelial: lymphadenopathy. Skin: acne, alopecia, angioedema, bullous eruption, dermatitis, dry skin, eczema, erythematous rash, furunculosis, hyperkeratosis, hypertrichosis, increased sweating, maculopapular rash, photosensitivity reaction, photosensitivity toxic reaction, pruritus, purpura, rash, seborrhea, skin disorder, skin nodule, urticaria.
Special Senses: parosmia, taste loss, taste perversion. Vision: blindness, conjunctivitis, eye pain, glaucoma, loss of accommodation, ocular hemorrhage, xerophthalmia. Body as a Whole: accidental injury, asthenia, back pain, chest pain, enlarged abdomen, face edema, fever, generalized edema, hot flashes, increased weight, leg edema, malaise, nasal polyp, pain, pallor, periorbital edema, peripheral edema, rigors.
Occasional instances of transient, reversible hepatic transaminase elevations have occurred during cetirizine therapy. Hepatitis with significant transaminase elevation and elevated bilirubin in association with the use of cetirizine hydrochloride has been reported. Post-Marketing Experience In the post-marketing period, the following additional rare, but potentially severe adverse events have been reported: aggressive reaction, anaphylaxis, cholestasis, convulsions, glomerulonephritis, hallucinations, hemolytic anemia, hepatitis, orofacial dyskinesia, severe hypotension, stillbirth, suicidal ideation, suicide, thrombocytopenia, acute generalized exanthematous pustulosis (AGEP) and new onset pruritis-pruritis within a few days after discontinuation of cetirizine, usually after long-term use (e.g., months to years) of cetirizine.
To report SUSPECTED ADVERSE REACTIONS, contact Advagen Pharma Ltd., at +1-866-488-0312 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Adverse reaction frequency tables (US label) US FDA label
| Adverse Experiences | Placebo(N=309) | Cetirizine hydrochloride | |
| 5 mg(N=161) | 10 mg(N=215) | ||
| Headache | 12.3% | 11.0% | 14.0% |
| Pharyngitis | 2.9% | 6.2% | 2.8% |
| Abdominal pain | 1.9% | 4.4% | 5.6% |
| Coughing | 3.9% | 4.4% | 2.8% |
| Somnolence | 1.3% | 1.9% | 4.2% |
| Diarrhea | 1.3% | 3.1% | 1.9% |
| Epistaxis | 2.9% | 3.7% | 1.9% |
| Bronchospasm | 1.9% | 3.1% | 1.9% |
| Nausea | 1.9% | 1.9% | 2.8% |
| Vomiting | 1.0% | 2.5% | 2.3% |
Pharmacokinetics
Elimination: The mean elimination half-life in 146 healthy volunteers across multiple pharmacokinetic studies was 8.3 hours and the apparent total body clearance for cetirizine was approximately 53 mL/min.
Based on cross-study comparisons, the weight-normalized, apparent total body clearance was 81-111% greater and the elimination half-life was 33 to 41% shorter in the pediatric population than in adults.
Based on cross-study comparisons, the weight- normalized, apparent total body clearance was 304% greater and the elimination half-life was 63% shorter in this pediatric population compared to adults.
Pharmacokinetics (US label) US FDA label
CLINICAL PHARMACOLOGY Mechanism of Actions: Cetirizine, a human metabolite of hydroxyzine, is an antihistamine; its principal effects are mediated via selective inhibition of peripheral H 1 receptors. The antihistaminic activity of cetirizine has been clearly documented in a variety of animal and human models. In vivo and ex vivo animal models have shown negligible anticholinergic and antiserotonergic activity.
In clinical studies, however, dry mouth was more common with cetirizine than with placebo. In vitro receptor binding studies have shown no measurable affinity for other than H 1 receptors. Autoradiographic studies with radiolabeled cetirizine in the rat have shown negligible penetration into the brain. Ex vivo experiments in the mouse have shown that systemically administered cetirizine does not significantly occupy cerebral H 1 receptors.
Pharmacokinetics: Absorption: Cetirizine was rapidly absorbed with a time to maximum concentration (T max) of approximately 1 hour following oral administration of tablets or solution in adults. Comparable bioavailability was found between the tablet and solution dosage forms. When healthy volunteers were administered multiple doses of cetirizine (10 mg tablets once daily for 10 days), a mean peak plasma concentration (C max) of 311 ng/mL was observed.
No accumulation was observed. Cetirizine pharmacokinetics were linear for oral doses ranging from 5 to 60 mg. Food had no effect on the extent of cetirizine exposure (AUC) but T max was delayed by 1.7 hours and C max was decreased by 23% in the presence of food. Distribution: The mean plasma protein binding of cetirizine is 93%, independent of concentration in the range of 25-1000 ng/mL, which includes the therapeutic plasma levels observed.
Metabolism: A mass balance study in 6 healthy male volunteers indicated that 70% of the administered radioactivity was recovered in the urine and 10% in the feces. Approximately 50% of the radioactivity was identified in the urine as unchanged drug. Most of the rapid increase in peak plasma radioactivity was associated with parent drug, suggesting a low degree of first-pass metabolism.
Cetirizine is metabolized to a limited extent by oxidative O-dealkylation to a metabolite with negligible antihistaminic activity. The enzyme or enzymes responsible for this metabolism have not been identified. Elimination: The mean elimination half-life in 146 healthy volunteers across multiple pharmacokinetic studies was 8.3 hours and the apparent total body clearance for cetirizine was approximately 53 mL/min.
Interaction Studies Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, antipyrine, ketoconazole, erythromycin and azithromycin. No interactions were observed. In a multiple dose study of theophylline (400 mg once daily for 3 days) and cetirizine (20 mg once daily for 3 days), a 16% decrease in the clearance of cetirizine was observed.
The disposition of theophylline was not altered by concomitant cetirizine administration. Special Populations Pediatric Patients: In pediatric patients aged 2 to 5 years who received 5 mg of cetirizine, the mean C max was 660 ng/mL. Based on cross-study comparisons, the weight-normalized, apparent total body clearance was 81-111% greater and the elimination half-life was 33 to 41% shorter in the pediatric population than in adults.
In pediatric patients aged 6 to 23 months who received a single dose of 0.25 mg/kg cetirizine oral solution (mean dose 2.3 mg), the mean C max was 390 ng/mL. Based on cross-study comparisons, the weight- normalized, apparent total body clearance was 304% greater and the elimination half-life was 63% shorter in this pediatric population compared to adults.
The average AUC(0-t) in children 6 months to <2 years of age receiving the maximum dose of cetirizine solution (2.5 mg twice a day) is expected to be two-fold higher than that observed in adults receiving a dose of 10 mg cetirizine tablets once a day. Effect of Gender: The effect of gender on cetirizine pharmacokinetics has not been adequately studied.
Effect of Race: No race-related differences in the kinetics of cetirizine have been observed. Pharmacodynamics: Cetirizine hydrochloride at doses of 5 and 10 mg strongly inhibited the wheal and flare caused by intradermal injection of histamine in 19 pediatric volunteers (aged 5 to 12 years) and the activity persisted for at least 24 hours.
In a 35-day study in children aged 5 to 12, no tolerance to the antihistaminic (suppression of wheal and flare response) effects of cetirizine hydrochloride was found. In 10 infants 7 to 25 months of age who received 4 to 9 days of cetirizine in an oral solution (0.25 mg/kg bid), there was a 90% inhibition of histamine-induced (10 mg/mL) cutaneous wheal and 87% inhibition of the flare 12 hours after administration of the last dose.
The clinical relevance of this suppression of histamine-induced wheal and flare response on skin testing is unknown. The effects of intradermal injection of various other mediators or histamine releasers were also inhibited by cetirizine, as was response to a cold challenge in patients with cold-induced urticaria. In mildly asthmatic subjects, cetirizine hydrochloride at 5 to 20 mg blocked bronchoconstriction due to nebulized histamine, with virtually total blockade after a 20-mg dose.
In studies conducted for up to 12 hours following cutaneous antigen challenge, the late phase recruitment of eosinophils, neutrophils and basophils, components of the allergic inflammatory response, was inhibited by cetirizine hydrochloride at a dose of 20 mg. In four clinical studies in healthy adult males, no clinically significant mean increases in QTc were observed in cetirizine hydrochloride treated subjects.
In the first study, a placebo-controlled crossover trial, cetirizine hydrochloride was given at doses up to 60 mg per day, 6 times the maximum clinical dose, for 1 week, and no significant mean QTc prolongation occurred. In the second study, a crossover trial, cetirizine hydrochloride 20 mg and erythromycin (500 mg every 8 hours) were given alone and in combination.
There was no significant effect on QTc with the combination or with cetirizine hydrochloride alone. In the third trial, also a crossover study, cetirizine hydrochloride 20 mg and ketoconazole (400 mg per day) were given alone and in combination. Cetirizine hydrochloride caused a mean increase in QTc of 9.1 msec from baseline after 10 days of therapy.
Ketoconazole also increased QTc by 8.3 msec. The combination caused an increase of 17.4 msec, equal to the sum of the individual effects. Thus, there was no significant drug interaction on QTc with the combination of cetirizine hydrochloride and ketoconazole. In the fourth study, a placebo-controlled parallel trial, cetirizine hydrochloride 20 mg was given alone or in combination with azithromycin (500 mg as a single dose on the first day followed by 250 mg once daily).
There was no significant increase in QTc with cetirizine hydrochloride 20 mg alone or in combination with azithromycin. In a four-week clinical trial in pediatric patients aged 6 to 11 years, results of randomly obtained ECG measurements before treatment and after 2 weeks of treatment showed that cetirizine hydrochloride 5 or 10 mg did not increase QTc versus placebo.
In a one week clinical trial (N=86) of cetirizine hydrochloride oral solution (0.25 mg/kg bid) compared with placebo in pediatric patients 6 to 11 months of age, ECG measurements taken within 3 hours of the last dose did not show any ECG abnormalities or increases in QTc interval in either group compared to baseline assessments. Data from other studies where cetirizine hydrochloride was administered to patients 6-23 months of age were consistent with the findings in this study.
The effects of cetirizine hydrochloride on the QTc interval at doses higher than 10 mg have not been studied in children less than 12 years of age. In a six-week, placebo-controlled study of 186 patients (aged 12 to 64 years) with allergic rhinitis and mild to moderate asthma, cetirizine hydrochloride 10 mg once daily improved rhinitis symptoms and did not alter pulmonary function.
In a two-week, placebo-controlled clinical trial, a subset analysis of 65 pediatric (aged 6 to 11 years) allergic rhinitis patients with asthma showed cetirizine hydrochloride did not alter pulmonary function. These studies support the safety of administering cetirizine hydrochloride to pediatric and adult allergic rhinitis patients with mild to moderate asthma.
Clinical Studies: Multicenter, randomized, double-blind, clinical trials comparing cetirizine 5 to 20 mg to placebo in patients 12 years and older with perennial allergic rhinitis were conducted in the United States. Two of these showed significant reductions in symptoms of perennial allergic rhinitis for up to 8 weeks in duration.
Two 4-week multicenter, randomized, double-blind, clinical trials comparing cetirizine 5 to 20 mg to placebo in patients with chronic idiopathic urticaria were also conducted and showed significant improvement in symptoms of chronic idiopathic urticaria. In general, the 10-mg dose was more effective than the 5-mg dose and the 20-mg dose gave no added effect.
Some of these trials included pediatric patients aged 12 to 16 years. In addition, four multicenter, randomized, placebo-controlled, double-blind 2-4 week trials in 534 pediatric patients aged 6 to 11 years with seasonal allergic rhinitis were conducted in the United States at doses up to 10 mg.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Cetirizine 1 mg/mL, 30 mL Bottle | ₱50.90Reference ₱50.90 | per bottle | DPRI procurement range |
| Cetirizine 1 mg/mL, 60 mL Bottle | ₱21.30–₱78.48Reference ₱37.94 | per bottle | DPRI procurement range |
| Cetirizine (as Dihydrochloride) 2.5 mg/mL, 10mL Syrup | ₱35.88–₱130.00Reference ₱75.00 | per unit | DPRI procurement range |
| Cetirizine (as Dihydrochloride) 5 mg/5 mL, 30 mL Syrup | ₱19.50–₱70.00Reference ₱60.00 | per unit | DPRI procurement range |
| Cetirizine 10 mg Tablet | ₱0.29–₱27.50Reference ₱0.40 | per tablet | DPRI procurement range |
| Cetirizine 10 mg/mL, 10 mL Oral Drops | ₱21.30–₱120.00Reference ₱65.56 | per unit | DPRI procurement range |
| 1 mg/mL (as dihydrochloride) solution in 30 mL | ₱91.00 | per unit | PhilHealth GAMOT fixed fee |
| 1 mg/mL (as dihydrochloride) solution in 60 mL | ₱119.50 | per unit | PhilHealth GAMOT fixed fee |
| 2.5 mg/mL (as dihydrochloride) syrup (drops) in 10 mL | ₱126.50 | per unit | PhilHealth GAMOT fixed fee |
| 5 mg/5 mL (as dihydrochloride) syrup 30 mL | ₱122.50 | per unit | PhilHealth GAMOT fixed fee |
| 10 mg (as dihydrochloride) tablet | ₱11.25 | per tablet | PhilHealth GAMOT fixed fee |
| 10 mg/mL (as dihydrochloride) drops in 10 mL | ₱110.25 | per unit | PhilHealth GAMOT fixed fee |
PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf, as of October 13, 2026
Formulary and coverage
| Philippine National Formulary | Listed as Cetirizine (as dihydrochloride) |
| PNF listing | Oral: 10 mg tablet |
| PNF listing | Oral: 2.5 mg/mL syrup (oral drops), 10 mL |
| PNF listing | Oral: 10 mg/mL drops, 10 mL |
| PNF listing | Oral: 1 mg/mL solution, 30 mL and 60 mL |
| PNF listing | Oral: 5 mg/5 mL syrup, 30 mL |
| PhilHealth GAMOT | Yes (listed since July 28, 2025) |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Cetirizine hydrochloride · Advagen Pharma Ltd., [US FDA-approved label, version 1, March 6, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0956baea-f0ad-4aac-9464-831840db9230
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .